#ariba_ref_name	ref_name	gene	var_only	flag	reads	cluster	ref_len	ref_base_assembled	pc_ident	ctg	ctg_len	ctg_cov	known_var	var_type	var_seq_type	known_var_change	has_known_var	ref_ctg_change	ref_ctg_effect	ref_start	ref_end	ref_nt	ctg_start	ctg_end	ctg_nt	smtls_total_depth	smtls_nts	smtls_nts_depth	var_description	free_text
CRP.3000518.AP009048.4153663_4154296.461	CRP.3000518.AP009048.4153663_4154296.461	1	0	539	240	CRP	633	633	99.53	CRP.l6.c30.ctg.1	1021	12.3	0	.	p	.	0	K29T	NONSYN	85	87	AAG	280	282	ACG	8;8;8	A;C;G	8;8;8	.	CRP is a global regulator that represses MdtEF multidrug efflux pump expression.;CRP
Chlamydophila_psittaci_16S.3003485.AB001778.1.0_1507.3258	Chlamydophila_psittaci_16S.3003485.AB001778.1.0_1507.3258	0	0	528	164	Chlamydophila_psittaci_16S	1507	119	92.44	Chlamydophila_psittaci_16S.l15.c17.ctg.2	134	14.9	0	.	n	.	0	A888G	SNP	888	888	A	9	9	G	3	G	3	.	Chlamydophila psittaci 16S rRNA mutation conferring resistance to spectinomycin
Chlamydophila_psittaci_16S.3003485.AB001778.1.0_1507.3258	Chlamydophila_psittaci_16S.3003485.AB001778.1.0_1507.3258	0	0	528	164	Chlamydophila_psittaci_16S	1507	119	92.44	Chlamydophila_psittaci_16S.l15.c17.ctg.2	134	14.9	0	.	n	.	0	C897G	SNP	897	897	C	18	18	G	9	G	9	.	Chlamydophila psittaci 16S rRNA mutation conferring resistance to spectinomycin
Chlamydophila_psittaci_16S.3003485.AB001778.1.0_1507.3258	Chlamydophila_psittaci_16S.3003485.AB001778.1.0_1507.3258	0	0	528	164	Chlamydophila_psittaci_16S	1507	119	92.44	Chlamydophila_psittaci_16S.l15.c17.ctg.2	134	14.9	0	.	n	.	0	T898C	SNP	898	898	T	19	19	C	10	C	10	.	Chlamydophila psittaci 16S rRNA mutation conferring resistance to spectinomycin
Chlamydophila_psittaci_16S.3003485.AB001778.1.0_1507.3258	Chlamydophila_psittaci_16S.3003485.AB001778.1.0_1507.3258	0	0	528	164	Chlamydophila_psittaci_16S	1507	119	92.44	Chlamydophila_psittaci_16S.l15.c17.ctg.2	134	14.9	0	.	n	.	0	G906T	SNP	906	906	G	27	27	T	12	T	12	.	Chlamydophila psittaci 16S rRNA mutation conferring resistance to spectinomycin
Chlamydophila_psittaci_16S.3003485.AB001778.1.0_1507.3258	Chlamydophila_psittaci_16S.3003485.AB001778.1.0_1507.3258	0	0	528	164	Chlamydophila_psittaci_16S	1507	119	92.44	Chlamydophila_psittaci_16S.l15.c17.ctg.2	134	14.9	0	.	n	.	0	G908A	SNP	908	908	G	29	29	A	14	A	14	.	Chlamydophila psittaci 16S rRNA mutation conferring resistance to spectinomycin
Chlamydophila_psittaci_16S.3003485.AB001778.1.0_1507.3258	Chlamydophila_psittaci_16S.3003485.AB001778.1.0_1507.3258	0	0	528	164	Chlamydophila_psittaci_16S	1507	119	92.44	Chlamydophila_psittaci_16S.l15.c17.ctg.2	134	14.9	0	.	n	.	0	A918T	SNP	918	918	A	39	39	T	14	T	14	.	Chlamydophila psittaci 16S rRNA mutation conferring resistance to spectinomycin
Chlamydophila_psittaci_16S.3003485.AB001778.1.0_1507.3258	Chlamydophila_psittaci_16S.3003485.AB001778.1.0_1507.3258	0	0	528	164	Chlamydophila_psittaci_16S	1507	119	92.44	Chlamydophila_psittaci_16S.l15.c17.ctg.2	134	14.9	0	.	n	.	0	A943G	SNP	943	943	A	64	64	G	27	G	27	.	Chlamydophila psittaci 16S rRNA mutation conferring resistance to spectinomycin
Chlamydophila_psittaci_16S.3003485.AB001778.1.0_1507.3258	Chlamydophila_psittaci_16S.3003485.AB001778.1.0_1507.3258	0	0	528	164	Chlamydophila_psittaci_16S	1507	119	92.44	Chlamydophila_psittaci_16S.l15.c17.ctg.2	134	14.9	0	.	n	.	0	G991T	SNP	991	991	G	112	112	T	19	T	19	.	Chlamydophila psittaci 16S rRNA mutation conferring resistance to spectinomycin
Escherichia_coli_EF_Tu.3003370.NC_000913.3.3470144_3471329.3532	Escherichia_coli_EF_Tu.3003370.NC_000913.3.3470144_3471329.3532	1	1	165	880	Escherichia_coli_EF_Tu	1185	1030	99.81	Escherichia_coli_EF_Tu.l15.c30.ctg.1	1030	36.6	0	HET	.	.	.	C954T	.	954	954	C	819	819	C	32	C,T	17,15	.	Escherichia coli EF-Tu mutants conferring resistance to Enacyloxin IIa
Escherichia_coli_EF_Tu.3003370.NC_000913.3.3470144_3471329.3532	Escherichia_coli_EF_Tu.3003370.NC_000913.3.3470144_3471329.3532	1	1	165	880	Escherichia_coli_EF_Tu	1185	155	98.71	Escherichia_coli_EF_Tu.l15.c30.ctg.2	155	6.9	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Escherichia coli EF-Tu mutants conferring resistance to Enacyloxin IIa
Escherichia_coli_EF_Tu.3003370.NC_000913.3.3470144_3471329.3532	Escherichia_coli_EF_Tu.3003370.NC_000913.3.3470144_3471329.3532	1	1	165	880	Escherichia_coli_EF_Tu	1185	114	97.37	Escherichia_coli_EF_Tu.l15.c30.ctg.4	357	9.8	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Escherichia coli EF-Tu mutants conferring resistance to Enacyloxin IIa
Escherichia_coli_EF_Tu.3003370.NC_000913.3.3470144_3471329.3532	Escherichia_coli_EF_Tu.3003370.NC_000913.3.3470144_3471329.3532	1	1	165	880	Escherichia_coli_EF_Tu	1185	72	100.0	Escherichia_coli_EF_Tu.l15.c30.ctg.5	237	7.2	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Escherichia coli EF-Tu mutants conferring resistance to Enacyloxin IIa
Escherichia_coli_EF_Tu.3003370.NC_000913.3.3470144_3471329.3532	Escherichia_coli_EF_Tu.3003370.NC_000913.3.3470144_3471329.3532	1	1	165	880	Escherichia_coli_EF_Tu	1185	148	97.3	Escherichia_coli_EF_Tu.l15.c30.ctg.6	148	3.6	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Escherichia coli EF-Tu mutants conferring resistance to Enacyloxin IIa
Escherichia_coli_mutant.3003889.HG738867.2233288_2234647.3666	Escherichia_coli_mutant.3003889.HG738867.2233288_2234647.3666	1	1	539	350	Escherichia_coli_mutant_1	1359	1359	99.85	Escherichia_coli_mutant_1.l15.c4.ctg.1	1727	10.7	1	SNP	p	E448K	1	E448K	NONSYN	1342	1344	GAA	1553	1555	AAA	6;7;6	A;A;A	6;7;6	Escherichia_coli_mutant.3003889.HG738867.2233288_2234647.3666:1:1:E448K:.:Mutations to the active importer GlpT, which is involved with the uptake of many phosphorylated sugars, confer resistance to fosfomycin by reducing import of the drug into the bacteria.	Escherichia coli mutant GlpT conferring resistance to fosfomycin
Escherichia_coli_mutant.3003890.HG738867.2934266_2935658.3667	Escherichia_coli_mutant.3003890.HG738867.2934266_2935658.3667	1	1	27	452	Escherichia_coli_mutant	1392	1392	99.43	Escherichia_coli_mutant.l15.c4.ctg.1	1664	14.4	1	SNP	p	E350Q	0	.	.	1048	1050	GAA	1238	1240	GAA	23;23;22	G;A;A	23;23;21	Escherichia_coli_mutant.3003890.HG738867.2934266_2935658.3667:1:1:E350Q:.:Mutations to the active importer UhpT, which is involved with the uptake of many phosphorylated sugars, confer resistance to fosfomycin by reducing import of the drug into the bacteria.	Escherichia coli mutant UhpT conferring resistance to fosfomycin
H_NS.3000676.NC_002695.1737553_1737967.218	H_NS.3000676.NC_002695.1737553_1737967.218	1	0	27	126	H_NS	414	414	99.03	H_NS.l6.c4.ctg.1	432	11.5	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	H-NS is a histone-like protein involved in global gene regulation in Gram-negative bacteria. It is a repressor of the membrane fusion protein genes acrE, mdtE, and emrK as well as nearby genes of many RND-type multidrug exporters.;H-NS
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	640	1310	Pasteurella_multocida_16S	1551	127	94.49	Pasteurella_multocida_16S.l15.c17.ctg.1	127	33.8	0	.	n	.	0	A303G	SNP	303	303	A	6	6	G	26	G	25	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	640	1310	Pasteurella_multocida_16S	1551	127	94.49	Pasteurella_multocida_16S.l15.c17.ctg.1	127	33.8	0	.	n	.	0	G375A	SNP	375	375	G	78	78	A	27	A	26	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	640	1310	Pasteurella_multocida_16S	1551	127	94.49	Pasteurella_multocida_16S.l15.c17.ctg.1	127	33.8	0	.	n	.	0	G383C	SNP	383	383	G	86	86	C	12	C	11	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	640	1310	Pasteurella_multocida_16S	1551	127	94.49	Pasteurella_multocida_16S.l15.c17.ctg.1	127	33.8	0	.	n	.	0	G385C	SNP	385	385	G	88	88	C	8	C	8	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	640	1310	Pasteurella_multocida_16S	1551	127	94.49	Pasteurella_multocida_16S.l15.c17.ctg.1	127	33.8	0	.	n	.	0	C388G	SNP	388	388	C	91	91	G	5	G	5	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	640	1310	Pasteurella_multocida_16S	1551	127	94.49	Pasteurella_multocida_16S.l15.c17.ctg.1	127	33.8	0	.	n	.	0	C394T	SNP	394	394	C	97	97	T	3	T	3	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	640	1310	Pasteurella_multocida_16S	1551	127	94.49	Pasteurella_multocida_16S.l15.c17.ctg.1	127	33.8	0	.	n	.	0	A411T	SNP	411	411	A	114	114	T	2	T	2	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	640	1310	Pasteurella_multocida_16S	1551	526	91.65	Pasteurella_multocida_16S.l15.c17.ctg.2	567	57.4	0	.	n	.	0	T1041G	SNP	1041	1041	T	16	16	G	49	G	42	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	640	1310	Pasteurella_multocida_16S	1551	526	91.65	Pasteurella_multocida_16S.l15.c17.ctg.2	567	57.4	0	.	n	.	0	A1042T	SNP	1042	1042	A	17	17	T	52	T	45	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	640	1310	Pasteurella_multocida_16S	1551	526	91.65	Pasteurella_multocida_16S.l15.c17.ctg.2	567	57.4	0	.	n	.	0	A1136G	SNP	1136	1136	A	111	111	G	94	G	94	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	640	1310	Pasteurella_multocida_16S	1551	526	91.65	Pasteurella_multocida_16S.l15.c17.ctg.2	567	57.4	0	.	n	.	0	T1138C	SNP	1138	1138	T	113	113	C	91	C	91	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	640	1310	Pasteurella_multocida_16S	1551	526	91.65	Pasteurella_multocida_16S.l15.c17.ctg.2	567	57.4	0	.	n	.	0	T1142C	SNP	1142	1142	T	117	117	C	83	C	83	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	640	1310	Pasteurella_multocida_16S	1551	526	91.65	Pasteurella_multocida_16S.l15.c17.ctg.2	567	57.4	0	.	n	.	0	C1170T	SNP	1170	1170	C	145	145	T	64	T	64	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	640	1310	Pasteurella_multocida_16S	1551	526	91.65	Pasteurella_multocida_16S.l15.c17.ctg.2	567	57.4	0	.	n	.	0	T1220C	SNP	1220	1220	T	195	195	C	49	C	49	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	640	1310	Pasteurella_multocida_16S	1551	526	91.65	Pasteurella_multocida_16S.l15.c17.ctg.2	567	57.4	0	.	n	.	0	T1245C	SNP	1245	1245	T	220	220	C	42	C	42	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	640	1310	Pasteurella_multocida_16S	1551	526	91.65	Pasteurella_multocida_16S.l15.c17.ctg.2	567	57.4	0	.	n	.	0	G1253A	SNP	1253	1253	G	228	228	A	46	A	45	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	640	1310	Pasteurella_multocida_16S	1551	526	91.65	Pasteurella_multocida_16S.l15.c17.ctg.2	567	57.4	0	.	n	.	0	G1256A	SNP	1256	1256	G	231	231	A	47	A	47	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	640	1310	Pasteurella_multocida_16S	1551	526	91.65	Pasteurella_multocida_16S.l15.c17.ctg.2	567	57.4	0	.	n	.	0	C1258A	SNP	1258	1258	C	233	233	A	46	A	46	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	640	1310	Pasteurella_multocida_16S	1551	526	91.65	Pasteurella_multocida_16S.l15.c17.ctg.2	567	57.4	0	.	n	.	0	G1266T	SNP	1266	1266	G	241	241	T	51	T	51	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	640	1310	Pasteurella_multocida_16S	1551	526	91.65	Pasteurella_multocida_16S.l15.c17.ctg.2	567	57.4	0	.	n	.	0	T1267C	SNP	1267	1267	T	242	242	C	53	C	53	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	640	1310	Pasteurella_multocida_16S	1551	526	91.65	Pasteurella_multocida_16S.l15.c17.ctg.2	567	57.4	0	.	n	.	0	T1275C	SNP	1275	1275	T	250	250	C	56	C	56	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	640	1310	Pasteurella_multocida_16S	1551	526	91.65	Pasteurella_multocida_16S.l15.c17.ctg.2	567	57.4	0	.	n	.	0	G1276A	SNP	1276	1276	G	251	251	A	56	A	56	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	640	1310	Pasteurella_multocida_16S	1551	526	91.65	Pasteurella_multocida_16S.l15.c17.ctg.2	567	57.4	0	.	n	.	0	A1281G	SNP	1281	1281	A	256	256	G	56	G	56	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	640	1310	Pasteurella_multocida_16S	1551	526	91.65	Pasteurella_multocida_16S.l15.c17.ctg.2	567	57.4	0	.	n	.	0	T1283C	SNP	1283	1283	T	258	258	C	56	C	56	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	640	1310	Pasteurella_multocida_16S	1551	526	91.65	Pasteurella_multocida_16S.l15.c17.ctg.2	567	57.4	0	.	n	.	0	G1288T	SNP	1288	1288	G	263	263	T	56	T	56	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	640	1310	Pasteurella_multocida_16S	1551	526	91.65	Pasteurella_multocida_16S.l15.c17.ctg.2	567	57.4	0	.	n	.	0	A1296G	SNP	1296	1296	A	271	271	G	69	G	68	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	640	1310	Pasteurella_multocida_16S	1551	526	91.65	Pasteurella_multocida_16S.l15.c17.ctg.2	567	57.4	0	.	n	.	0	T1299G	SNP	1299	1299	T	274	274	G	71	G	70	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	640	1310	Pasteurella_multocida_16S	1551	526	91.65	Pasteurella_multocida_16S.l15.c17.ctg.2	567	57.4	0	.	n	.	0	A1300T	SNP	1300	1300	A	275	275	T	73	T	70	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	640	1310	Pasteurella_multocida_16S	1551	526	91.65	Pasteurella_multocida_16S.l15.c17.ctg.2	567	57.4	0	.	n	.	0	C1356T	SNP	1356	1356	C	331	331	T	60	T	60	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	640	1310	Pasteurella_multocida_16S	1551	526	91.65	Pasteurella_multocida_16S.l15.c17.ctg.2	567	57.4	0	.	n	.	0	A1358G	SNP	1358	1358	A	333	333	G	58	G	58	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	640	1310	Pasteurella_multocida_16S	1551	526	91.65	Pasteurella_multocida_16S.l15.c17.ctg.2	567	57.4	0	.	n	.	0	T1368C	SNP	1368	1368	T	343	343	C	38	C	38	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	640	1310	Pasteurella_multocida_16S	1551	526	91.65	Pasteurella_multocida_16S.l15.c17.ctg.2	567	57.4	0	.	n	.	0	G1370A	SNP	1370	1370	G	345	345	A	32	A	32	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	640	1310	Pasteurella_multocida_16S	1551	526	91.65	Pasteurella_multocida_16S.l15.c17.ctg.2	567	57.4	0	.	n	.	0	C1406.	DEL	1406	1406	C	380	380	C	27	C	27	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	640	1310	Pasteurella_multocida_16S	1551	526	91.65	Pasteurella_multocida_16S.l15.c17.ctg.2	567	57.4	0	.	n	.	0	.1409C	INS	1409	1409	T	384	384	C	24	C	23	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	640	1310	Pasteurella_multocida_16S	1551	526	91.65	Pasteurella_multocida_16S.l15.c17.ctg.2	567	57.4	0	.	n	.	0	C1431A	SNP	1431	1431	C	406	406	A	5	A	5	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	640	1310	Pasteurella_multocida_16S	1551	526	91.65	Pasteurella_multocida_16S.l15.c17.ctg.2	567	57.4	0	.	n	.	0	C1432A	SNP	1432	1432	C	407	407	A	5	A	5	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	640	1310	Pasteurella_multocida_16S	1551	526	91.65	Pasteurella_multocida_16S.l15.c17.ctg.2	567	57.4	0	.	n	.	0	A1441G	SNP	1441	1441	A	416	416	G	4	G	4	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	640	1310	Pasteurella_multocida_16S	1551	526	91.65	Pasteurella_multocida_16S.l15.c17.ctg.2	567	57.4	0	.	n	.	0	T1464C	SNP	1464	1464	T	439	439	C	9	C	9	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	640	1310	Pasteurella_multocida_16S	1551	526	91.65	Pasteurella_multocida_16S.l15.c17.ctg.2	567	57.4	0	.	n	.	0	G1473T	SNP	1473	1473	G	448	448	T	34	T	33	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	640	1310	Pasteurella_multocida_16S	1551	526	91.65	Pasteurella_multocida_16S.l15.c17.ctg.2	567	57.4	0	.	n	.	0	A1475G	SNP	1475	1475	A	450	450	G	38	G	38	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	640	1310	Pasteurella_multocida_16S	1551	526	91.65	Pasteurella_multocida_16S.l15.c17.ctg.2	567	57.4	0	.	n	.	0	A1548T	SNP	1548	1548	A	523	523	T	34	T	34	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	640	1310	Pasteurella_multocida_16S	1551	526	91.65	Pasteurella_multocida_16S.l15.c17.ctg.2	567	57.4	1	SNP	n	C1194G	0	.	.	1194	1194	C	169	169	C	49	C	49	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252:0:0:C1194G:.:Point mutations in the helix 34 region of 16S rRNA of Pasteurella multocida can confer resistance to spectinomycin	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	640	1310	Pasteurella_multocida_16S	1551	526	91.65	Pasteurella_multocida_16S.l15.c17.ctg.2	567	57.4	0	HET	.	.	.	C1040T	.	1040	1040	T	15	15	C	40	C,T	24,9	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	640	1310	Pasteurella_multocida_16S	1551	140	96.43	Pasteurella_multocida_16S.l15.c17.ctg.3	142	80.8	0	.	n	.	0	T870C	SNP	870	870	T	11	11	C	34	C	24	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	640	1310	Pasteurella_multocida_16S	1551	140	96.43	Pasteurella_multocida_16S.l15.c17.ctg.3	142	80.8	0	.	n	.	0	A872T	SNP	872	872	A	13	13	T	41	T	31	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	640	1310	Pasteurella_multocida_16S	1551	140	96.43	Pasteurella_multocida_16S.l15.c17.ctg.3	142	80.8	0	.	n	.	0	A876G	SNP	876	876	A	17	17	G	45	G	35	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	640	1310	Pasteurella_multocida_16S	1551	140	96.43	Pasteurella_multocida_16S.l15.c17.ctg.3	142	80.8	0	.	n	.	0	C990G	SNP	990	990	C	131	131	G	32	G	32	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
PmrB.3003583.NC_007779.4336858_4337950.2119	PmrB.3003583.NC_007779.4336858_4337950.2119	1	0	539	370	PmrB_1	1092	1092	99.27	PmrB_1.l15.c4.ctg.1	1431	13.4	0	.	p	.	0	H2R	NONSYN	4	6	CAT	239	241	CGT	18;20;20	C;G;T	18;19;20	.	Histidine protein kinase sensor Lipid A modification gene; part of a two-component system involved in polymyxin resistance that senses high extracellular Fe(2+);PmrB
PmrB.3003583.NC_007779.4336858_4337950.2119	PmrB.3003583.NC_007779.4336858_4337950.2119	1	0	539	370	PmrB_1	1092	1092	99.27	PmrB_1.l15.c4.ctg.1	1431	13.4	0	.	p	.	0	D283G	NONSYN	847	849	GAC	1082	1084	GGC	15;14;14	G;G;C	15;14;14	.	Histidine protein kinase sensor Lipid A modification gene; part of a two-component system involved in polymyxin resistance that senses high extracellular Fe(2+);PmrB
PmrC.3003576.AP009048.4338624_4340268.2117	PmrC.3003576.AP009048.4338624_4340268.2117	1	0	539	532	PmrC	1644	1644	99.15	PmrC.l6.c30.ctg.1	1859	15.0	0	.	p	.	0	R8S	NONSYN	22	24	AGA	137	139	AGC	16;16;16	A;G;C	16;16;16	.	PmrC mediates the modification of Lipid A by the addition of 4-amino-4-deoxy-L-arabinose (L-Ara4N) and phosphoethanolamine, resulting in a less negative cell membrane and decreased binding of polymyxin B.;PmrC
PmrC.3003576.AP009048.4338624_4340268.2117	PmrC.3003576.AP009048.4338624_4340268.2117	1	0	539	532	PmrC	1644	1644	99.15	PmrC.l6.c30.ctg.1	1859	15.0	0	.	p	.	0	I142L	NONSYN	424	426	ATA	539	541	CTA	12;13;14	C;T;A	12;13;14	.	PmrC mediates the modification of Lipid A by the addition of 4-amino-4-deoxy-L-arabinose (L-Ara4N) and phosphoethanolamine, resulting in a less negative cell membrane and decreased binding of polymyxin B.;PmrC
PmrC.3003576.AP009048.4338624_4340268.2117	PmrC.3003576.AP009048.4338624_4340268.2117	1	0	539	532	PmrC	1644	1644	99.15	PmrC.l6.c30.ctg.1	1859	15.0	0	.	p	.	0	R315Q	NONSYN	943	945	CGA	1058	1060	CAA	16;16;14	C;A;A	16;16;14	.	PmrC mediates the modification of Lipid A by the addition of 4-amino-4-deoxy-L-arabinose (L-Ara4N) and phosphoethanolamine, resulting in a less negative cell membrane and decreased binding of polymyxin B.;PmrC
PmrC.3003576.AP009048.4338624_4340268.2117	PmrC.3003576.AP009048.4338624_4340268.2117	1	0	539	532	PmrC	1644	1644	99.15	PmrC.l6.c30.ctg.1	1859	15.0	0	.	p	.	0	D348G	NONSYN	1042	1044	GAT	1157	1159	GGT	16;17;17	G;G;T	16;17;17	.	PmrC mediates the modification of Lipid A by the addition of 4-amino-4-deoxy-L-arabinose (L-Ara4N) and phosphoethanolamine, resulting in a less negative cell membrane and decreased binding of polymyxin B.;PmrC
PmrC.3003576.AP009048.4338624_4340268.2117	PmrC.3003576.AP009048.4338624_4340268.2117	1	0	539	532	PmrC	1644	1644	99.15	PmrC.l6.c30.ctg.1	1859	15.0	0	.	p	.	0	I538V	NONSYN	1612	1614	ATT	1727	1729	GTT	7;7;7	G;T;T	7;7;7	.	PmrC mediates the modification of Lipid A by the addition of 4-amino-4-deoxy-L-arabinose (L-Ara4N) and phosphoethanolamine, resulting in a less negative cell membrane and decreased binding of polymyxin B.;PmrC
PmrE.3003577.U00096.2098446_2099613.2116	PmrE.3003577.U00096.2098446_2099613.2116	1	0	539	784	PmrE	1167	1167	96.92	PmrE.l15.c4.ctg.1	1596	26.4	0	.	p	.	0	A125E	NONSYN	373	375	GCA	574	576	GAA	34;34;33	G;A;A	34;34;33	.	PmrE is required for the synthesis and transfer of 4-amino-4-deoxy-L-arabinose (Ara4N) to Lipid A, which allows gram-negative bacteria to resist the antimicrobial activity of cationic antimicrobial peptides and antibiotics such as polymyxin;PmrE
PmrE.3003577.U00096.2098446_2099613.2116	PmrE.3003577.U00096.2098446_2099613.2116	1	0	539	784	PmrE	1167	1167	96.92	PmrE.l15.c4.ctg.1	1596	26.4	0	.	p	.	0	M185T	NONSYN	553	555	ATG	754	756	ACC	16;17;19	A;C;C	16;17;19	.	PmrE is required for the synthesis and transfer of 4-amino-4-deoxy-L-arabinose (Ara4N) to Lipid A, which allows gram-negative bacteria to resist the antimicrobial activity of cationic antimicrobial peptides and antibiotics such as polymyxin;PmrE
PmrE.3003577.U00096.2098446_2099613.2116	PmrE.3003577.U00096.2098446_2099613.2116	1	0	539	784	PmrE	1167	1167	96.92	PmrE.l15.c4.ctg.1	1596	26.4	0	.	p	.	0	S225T	NONSYN	673	675	TCC	874	876	ACT	16;16;15	A;C;T	16;16;15	.	PmrE is required for the synthesis and transfer of 4-amino-4-deoxy-L-arabinose (Ara4N) to Lipid A, which allows gram-negative bacteria to resist the antimicrobial activity of cationic antimicrobial peptides and antibiotics such as polymyxin;PmrE
PmrE.3003577.U00096.2098446_2099613.2116	PmrE.3003577.U00096.2098446_2099613.2116	1	0	539	784	PmrE	1167	1167	96.92	PmrE.l15.c4.ctg.1	1596	26.4	0	.	p	.	0	T355I	NONSYN	1063	1065	ACC	1264	1266	ATC	9;10;11	A;T;C	9;10;11	.	PmrE is required for the synthesis and transfer of 4-amino-4-deoxy-L-arabinose (Ara4N) to Lipid A, which allows gram-negative bacteria to resist the antimicrobial activity of cationic antimicrobial peptides and antibiotics such as polymyxin;PmrE
PmrF.3003578.U00096.2367070_2368039.2115	PmrF.3003578.U00096.2367070_2368039.2115	1	0	27	298	PmrF	969	969	99.38	PmrF.l15.c30.ctg.1	1456	10.9	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	PmrF is required for the synthesis and transfer of 4-amino-4-deoxy-L-arabinose (Ara4N) to Lipid A, which allows gram-negative bacteria to resist the antimicrobial activity of cationic antimicrobial peptides and antibiotics such as polymyxin;PmrF
acrD.3000491.NC_007779.2586250_2589364.664	acrD.3000491.NC_007779.2586250_2589364.664	1	0	539	734	acrD	3114	3114	99.1	acrD.l6.c4.ctg.1	3511	11.2	0	.	p	.	0	T85I	NONSYN	253	255	ACC	471	473	ATC	11;11;11	A;T;C	11;11;11	.	AcrD is an aminoglycoside efflux pump expressed in E. coli. Its expression can be induced by indole, and is regulated by baeRS and cpxAR.;acrD
acrD.3000491.NC_007779.2586250_2589364.664	acrD.3000491.NC_007779.2586250_2589364.664	1	0	539	734	acrD	3114	3114	99.1	acrD.l6.c4.ctg.1	3511	11.2	0	.	p	.	0	Q656K	NONSYN	1966	1968	CAA	2184	2186	AAG	10;9;9	A;A;G	10;9;9	.	AcrD is an aminoglycoside efflux pump expressed in E. coli. Its expression can be induced by indole, and is regulated by baeRS and cpxAR.;acrD
acrE.3000499.U00096.3413863_3415021.333	acrE.3000499.U00096.3413863_3415021.333	1	0	539	292	acrE	1158	1158	98.79	acrE.l15.c30.ctg.1	1339	10.9	0	.	p	.	0	A22V	NONSYN	64	66	GCC	177	179	GTC	10;9;9	G;T;C	9;9;9	.	AcrE is a membrane fusion protein, similar to AcrA.;acrE
acrE.3000499.U00096.3413863_3415021.333	acrE.3000499.U00096.3413863_3415021.333	1	0	539	292	acrE	1158	1158	98.79	acrE.l15.c30.ctg.1	1339	10.9	0	.	p	.	0	S269C	NONSYN	805	807	AGC	918	920	TGC	14;14;12	T;G;C	14;14;12	.	AcrE is a membrane fusion protein, similar to AcrA.;acrE
acrF.3000502.U00096.3415032_3418137.700	acrF.3000502.U00096.3415032_3418137.700	1	0	515	876	acrF	3105	2993	98.76	acrF.l15.c4.ctg.1	3185	14.0	0	.	p	.	0	S46trunc	TRUNC	136	136	T	24	24	T	1	T	1	.	AcrF is a inner membrane transporter, similar to AcrB.;acrF
acrF.3000502.U00096.3415032_3418137.700	acrF.3000502.U00096.3415032_3418137.700	1	0	515	876	acrF	3105	2993	98.76	acrF.l15.c4.ctg.1	3185	14.0	0	.	p	.	0	G148D	NONSYN	442	444	GGC	330	332	GAC	15;15;15	G;A;C	15;14;15	.	AcrF is a inner membrane transporter, similar to AcrB.;acrF
acrF.3000502.U00096.3415032_3418137.700	acrF.3000502.U00096.3415032_3418137.700	1	0	515	876	acrF	3105	2993	98.76	acrF.l15.c4.ctg.1	3185	14.0	0	.	p	.	0	F240L	NONSYN	718	720	TTT	606	608	TTA	9;9;9	T;T;A	9;9;9	.	AcrF is a inner membrane transporter, similar to AcrB.;acrF
acrF.3000502.U00096.3415032_3418137.700	acrF.3000502.U00096.3415032_3418137.700	1	0	515	876	acrF	3105	2993	98.76	acrF.l15.c4.ctg.1	3185	14.0	0	.	p	.	0	K599N	NONSYN	1795	1797	AAG	1683	1685	AAT	9;8;9	A;A;T	9;8;8	.	AcrF is a inner membrane transporter, similar to AcrB.;acrF
acrF.3000502.U00096.3415032_3418137.700	acrF.3000502.U00096.3415032_3418137.700	1	0	515	876	acrF	3105	2993	98.76	acrF.l15.c4.ctg.1	3185	14.0	0	.	p	.	0	N637S	NONSYN	1909	1911	AAT	1797	1799	AGT	13;13;13	A;G;T	13;13;13	.	AcrF is a inner membrane transporter, similar to AcrB.;acrF
acrF.3000502.U00096.3415032_3418137.700	acrF.3000502.U00096.3415032_3418137.700	1	0	515	876	acrF	3105	2993	98.76	acrF.l15.c4.ctg.1	3185	14.0	0	.	p	.	0	L770V	NONSYN	2308	2310	TTG	2196	2198	GTG	10;10;10	G;T;G	10;10;10	.	AcrF is a inner membrane transporter, similar to AcrB.;acrF
acrF.3000502.U00096.3415032_3418137.700	acrF.3000502.U00096.3415032_3418137.700	1	0	515	876	acrF	3105	2993	98.76	acrF.l15.c4.ctg.1	3185	14.0	0	.	p	.	0	E955K	NONSYN	2863	2865	GAG	2751	2753	AAG	10;10;10	A;A;G	10;10;10	.	AcrF is a inner membrane transporter, similar to AcrB.;acrF
acrF.3000502.U00096.3415032_3418137.700	acrF.3000502.U00096.3415032_3418137.700	1	0	515	876	acrF	3105	90	100.0	acrF.l15.c4.ctg.3	135	10.8	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	AcrF is a inner membrane transporter, similar to AcrB.;acrF
acrR.3003807.NC_000913.3.485760_486408.3575	acrR.3003807.NC_000913.3.485760_486408.3575	1	1	27	194	acrR_2	648	648	99.54	acrR_2.l15.c4.ctg.1	1001	10.2	1	SNP	p	R45C	0	.	.	133	135	CGC	333	335	CGC	11;10;12	C;G;C	11;10;12	acrR.3003807.NC_000913.3.485760_486408.3575:1:1:R45C:.:AcrR is a repressor of the AcrAB-TolC multidrug efflux complex. AcrR mutations result in high level antibiotic resistance. The mutations associated with this model are specific to E. coli.	Escherichia coli acrR mutants resulting in antibiotic resistance
acrS.3000656.U00096.3412802_3413465.551	acrS.3000656.U00096.3412802_3413465.551	1	0	539	176	acrS	663	663	98.79	acrS.l6.c4.ctg.1	1010	9.2	0	.	p	.	0	L34F	NONSYN	100	102	CTC	280	282	TTC	8;8;8	T;T;C	8;8;8	.	AcrS is a repressor of the AcrAB efflux complex and is associated with the expression of AcrEF. AcrS is believed to regulate a switch between AcrAB and AcrEF efflux.;acrS
acrS.3000656.U00096.3412802_3413465.551	acrS.3000656.U00096.3412802_3413465.551	1	0	539	176	acrS	663	663	98.79	acrS.l6.c4.ctg.1	1010	9.2	0	.	p	.	0	E122G	NONSYN	364	366	GAG	544	546	GGG	15;14;14	G;G;G	15;14;14	.	AcrS is a repressor of the AcrAB efflux complex and is associated with the expression of AcrEF. AcrS is believed to regulate a switch between AcrAB and AcrEF efflux.;acrS
adiY.3003828.NC_000913.3.4337167_4337929.3591	adiY.3003828.NC_000913.3.4337167_4337929.3591	1	0	539	266	adiY	762	762	99.61	adiY.l15.c4.ctg.1	1157	12.2	0	.	p	.	0	V136L	NONSYN	406	408	GTT	606	608	CTT	20;20;21	C;T;T	20;19;21	.	adiY;adiY is a DNA-binding transcriptional activator of the adi system. Implicated in arginine-dependent acid resistance in Escherichia coli.
alaS.3003830.NC_000913.3.2819380_2822011.3592	alaS.3003830.NC_000913.3.2819380_2822011.3592	1	0	539	800	alaS	2631	2631	98.94	alaS.l6.c4.ctg.1	3037	14.1	0	.	p	.	0	T618A	NONSYN	1852	1854	ACA	2045	2047	GCA	20;20;19	G;C;A	20;19;17	.	alanyl-tRNA synthetase conferring resistance to novobiocin in Escherichia coli;aminocoumarin resistant alaS
alaS.3003830.NC_000913.3.2819380_2822011.3592	alaS.3003830.NC_000913.3.2819380_2822011.3592	1	0	539	800	alaS	2631	2631	98.94	alaS.l6.c4.ctg.1	3037	14.1	0	.	p	.	0	A705T	NONSYN	2113	2115	GCC	2306	2308	ACC	21;21;20	A;C;C	20;21;20	.	alanyl-tRNA synthetase conferring resistance to novobiocin in Escherichia coli;aminocoumarin resistant alaS
alaS.3003830.NC_000913.3.2819380_2822011.3592	alaS.3003830.NC_000913.3.2819380_2822011.3592	1	0	539	800	alaS	2631	2631	98.94	alaS.l6.c4.ctg.1	3037	14.1	0	.	p	.	0	V808A	NONSYN	2422	2424	GTC	2615	2617	GCC	14;14;15	G;C;C	14;14;15	.	alanyl-tRNA synthetase conferring resistance to novobiocin in Escherichia coli;aminocoumarin resistant alaS
arnA.3002985.U00096.2368038_2370021.355	arnA.3002985.U00096.2368038_2370021.355	1	0	513	380	arnA_1	1983	1725	98.43	arnA_1.l6.c4.ctg.1	1873	10.0	0	.	p	.	0	Y89C	NONSYN	265	267	TAC	7	9	TGC	1;2;2	T;G;C	1;2;2	.	arnA modifies lipid A with 4-amino-4-deoxy-L-arabinose (Ara4N) which allows gram-negative bacteria to resist the antimicrobial activity of cationic antimicrobial peptides and antibiotics such as polymyxin. arnA is found in E. coli and P. aeruginosa.;arnA
arnA.3002985.U00096.2368038_2370021.355	arnA.3002985.U00096.2368038_2370021.355	1	0	513	380	arnA_1	1983	1725	98.43	arnA_1.l6.c4.ctg.1	1873	10.0	0	.	p	.	0	I150V	NONSYN	448	450	ATT	190	192	GTT	8;8;9	G;T;T	8;8;9	.	arnA modifies lipid A with 4-amino-4-deoxy-L-arabinose (Ara4N) which allows gram-negative bacteria to resist the antimicrobial activity of cationic antimicrobial peptides and antibiotics such as polymyxin. arnA is found in E. coli and P. aeruginosa.;arnA
arnA.3002985.U00096.2368038_2370021.355	arnA.3002985.U00096.2368038_2370021.355	1	0	513	380	arnA_1	1983	1725	98.43	arnA_1.l6.c4.ctg.1	1873	10.0	0	.	p	.	0	R200H	NONSYN	598	600	CGC	340	342	CAC	2;2;1	C;A;C	2;2;1	.	arnA modifies lipid A with 4-amino-4-deoxy-L-arabinose (Ara4N) which allows gram-negative bacteria to resist the antimicrobial activity of cationic antimicrobial peptides and antibiotics such as polymyxin. arnA is found in E. coli and P. aeruginosa.;arnA
arnA.3002985.U00096.2368038_2370021.355	arnA.3002985.U00096.2368038_2370021.355	1	0	513	380	arnA_1	1983	1725	98.43	arnA_1.l6.c4.ctg.1	1873	10.0	0	.	p	.	0	T295M	NONSYN	883	885	ACG	625	627	ATG	10;10;10	A;T;G	10;10;9	.	arnA modifies lipid A with 4-amino-4-deoxy-L-arabinose (Ara4N) which allows gram-negative bacteria to resist the antimicrobial activity of cationic antimicrobial peptides and antibiotics such as polymyxin. arnA is found in E. coli and P. aeruginosa.;arnA
arnA.3002985.U00096.2368038_2370021.355	arnA.3002985.U00096.2368038_2370021.355	1	0	513	380	arnA_1	1983	1725	98.43	arnA_1.l6.c4.ctg.1	1873	10.0	0	.	p	.	0	H627R	NONSYN	1879	1881	CAC	1621	1623	CGC	14;14;14	C;G;C	14;14;14	.	arnA modifies lipid A with 4-amino-4-deoxy-L-arabinose (Ara4N) which allows gram-negative bacteria to resist the antimicrobial activity of cationic antimicrobial peptides and antibiotics such as polymyxin. arnA is found in E. coli and P. aeruginosa.;arnA
arnA.3002985.U00096.2368038_2370021.355	arnA.3002985.U00096.2368038_2370021.355	1	0	513	380	arnA_1	1983	136	97.06	arnA_1.l6.c4.ctg.2	136	5.5	0	.	p	.	0	D77E	NONSYN	229	231	GAT	119	121	GAG	1;1;1	G;A;G	1;1;1	.	arnA modifies lipid A with 4-amino-4-deoxy-L-arabinose (Ara4N) which allows gram-negative bacteria to resist the antimicrobial activity of cationic antimicrobial peptides and antibiotics such as polymyxin. arnA is found in E. coli and P. aeruginosa.;arnA
bacA.3002986.U00096.3203309_3204131.36	bacA.3002986.U00096.3203309_3204131.36	1	0	539	206	bacA	822	822	98.54	bacA.l6.c4.ctg.1	1041	9.9	0	.	p	.	0	S221T	NONSYN	661	663	AGC	729	731	ACC	10;10;8	A;C;C	10;10;8	.	bacA;bacA is a gene that recycles undecaprenyl pyrophosphate during cell wall biosynthesis which confers resistance to bacitracin
bacA.3002986.U00096.3203309_3204131.36	bacA.3002986.U00096.3203309_3204131.36	1	0	539	206	bacA	822	822	98.54	bacA.l6.c4.ctg.1	1041	9.9	0	.	p	.	0	P225S	NONSYN	673	675	CCG	741	743	TCG	7;7;7	T;C;G	7;7;7	.	bacA;bacA is a gene that recycles undecaprenyl pyrophosphate during cell wall biosynthesis which confers resistance to bacitracin
baeR.3000828.NC_007779.2166412_2167135.676	baeR.3000828.NC_007779.2166412_2167135.676	1	0	539	474	baeR	723	723	97.65	baeR.l15.c4.ctg.1	1020	24.4	0	.	p	.	0	S214F	NONSYN	640	642	TCT	842	844	TTT	15;15;14	T;T;T	15;15;14	.	baeR;BaeR is a response regulator that promotes the expression of MdtABC and AcrD efflux complexes.
baeS.3000829.AP009048.2165012_2166416.608	baeS.3000829.AP009048.2165012_2166416.608	1	0	539	960	baeS	1404	1404	98.86	baeS.l15.c30.ctg.1	1610	31.2	0	.	p	.	0	Q376K	NONSYN	1126	1128	CAA	1321	1323	AAA	14;15;14	A;A;A	9;14;14	.	baeS;BaeS is a sensor kinase in the BaeSR regulatory system. While it phosphorylates BaeR to increase its activity, BaeS is not necessary for overexpressed BaeR to confer resistance.
baeS.3000829.AP009048.2165012_2166416.608	baeS.3000829.AP009048.2165012_2166416.608	1	0	539	960	baeS	1404	1404	98.86	baeS.l15.c30.ctg.1	1610	31.2	0	.	p	.	0	G380E	NONSYN	1138	1140	GGG	1333	1335	GAG	15;15;17	G;A;G	13;11;15	.	baeS;BaeS is a sensor kinase in the BaeSR regulatory system. While it phosphorylates BaeR to increase its activity, BaeS is not necessary for overexpressed BaeR to confer resistance.
baeS.3000829.AP009048.2165012_2166416.608	baeS.3000829.AP009048.2165012_2166416.608	1	0	539	960	baeS	1404	1404	98.86	baeS.l15.c30.ctg.1	1610	31.2	0	.	p	.	0	R382H	NONSYN	1144	1146	CGC	1339	1341	CAC	15;15;15	C;A;C	15;15;15	.	baeS;BaeS is a sensor kinase in the BaeSR regulatory system. While it phosphorylates BaeR to increase its activity, BaeS is not necessary for overexpressed BaeR to confer resistance.
baeS.3000829.AP009048.2165012_2166416.608	baeS.3000829.AP009048.2165012_2166416.608	1	0	539	960	baeS	1404	1404	98.86	baeS.l15.c30.ctg.1	1610	31.2	0	.	p	.	0	D400E	NONSYN	1198	1200	GAT	1393	1395	GAG	22;22;23	G;A;G	22;22;23	.	baeS;BaeS is a sensor kinase in the BaeSR regulatory system. While it phosphorylates BaeR to increase its activity, BaeS is not necessary for overexpressed BaeR to confer resistance.
cpxA.3000830.NC_002695.4903561_4904935.605	cpxA.3000830.NC_002695.4903561_4904935.605	1	0	539	836	cpxA	1374	1374	98.76	cpxA.l15.c4.ctg.1	2000	22.6	0	.	p	.	0	A231T	NONSYN	691	693	GCG	1070	1072	ACG	27;29;28	A;C;G	27;29;28	.	CpxA is a membrane-localized sensor kinase that is activated by envelope stress. It starts a kinase cascade that activates CpxR, which promotes efflux complex expression.;cpxA
cpxR.3000831.NC_002695.4904931_4905630.142	cpxR.3000831.NC_002695.4904931_4905630.142	1	0	27	482	cpxR	699	699	99.43	cpxR.l15.c4.ctg.1	1184	21.9	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	cpxR;CpxR is a regulator that promotes acrD expression when phosphorylated by a cascade involving CpxA, a sensor kinase.
cysB.3003840.NC_000913.3.1333854_1334829.3604	cysB.3003840.NC_000913.3.1333854_1334829.3604	1	0	539	282	cysB	975	975	99.28	cysB.l6.c4.ctg.1	1319	11.5	0	.	p	.	0	T132I	NONSYN	394	396	ACA	579	581	ATA	7;6;6	A;T;A	7;6;6	.	Positive regulator of gene expression in the cysteine regulon. cysB mutants confer resistance to novobiocin, an aminocoumarin antibiotic, in Escherichia coli.;aminocoumarin resistant cysB
emrA.3000027.AP009048.2810082_2811255.411	emrA.3000027.AP009048.2810082_2811255.411	1	0	539	324	emrA	1173	1173	98.38	emrA.l15.c30.ctg.1	1297	12.4	0	.	p	.	0	I219V	NONSYN	655	657	ATC	672	674	GTC	17;17;17	G;T;C	17;14;17	.	EmrA is a membrane fusion protein, providing an efflux pathway with EmrB and TolC between the inner and outer membranes of E. coli, a Gram-negative bacterium.;emrA
emrB.3000074.U00096.2812615_2814154.20	emrB.3000074.U00096.2812615_2814154.20	1	0	27	504	emrB	1539	1539	99.81	emrB.l15.c4.ctg.1	1858	14.3	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	emrB is a translocase in the emrB -TolC efflux protein in E. coli. It recognizes substrates including carbonyl cyanide m-chlorophenylhydrazone (CCCP), nalidixic acid, and thioloactomycin.;emrB
emrD.3000309.GG749185.1.116812_118003.3622	emrD.3000309.GG749185.1.116812_118003.3622	1	0	539	350	emrD	1191	1191	98.57	emrD.l15.c17.ctg.1	1360	13.1	0	.	p	.	0	G209S	NONSYN	625	627	GGC	767	769	AGC	9;9;9	A;G;C	9;9;9	.	emrD;EmrD is a multidrug transporter from the Major Facilitator Superfamily (MFS) primarily found in Escherichia coli. EmrD couples efflux of amphipathic compounds with proton import across the plasma membrane.
emrE.3000264.NC_007779.567537_567870.260	emrE.3000264.NC_007779.567537_567870.260	1	0	16	52	emrE_1	333	93	96.77	emrE_1.l15.c4.ctg.1	93	13.9	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	EmrE is a small multidrug transporter that functions as a homodimer and that couples the efflux of small polyaromatic cations from the cell with the import of protons down an electrochemical gradient. EmrE is found in E. coli and P. aeruginosa.;emrE
emrK.3000206.D78168.536_1592.173	emrK.3000206.D78168.536_1592.173	1	0	539	232	emrK	1056	1056	98.2	emrK.l15.c30.ctg.1	1193	9.5	0	.	p	.	0	K176R	NONSYN	526	528	AAG	631	633	AGG	12;12;12	A;G;G	12;12;12	.	emrK is a membrane fusion protein that is a homolog of EmrA. Together with the inner membrane transporter EmrY and the outer membrane channel TolC, it mediates multidrug efflux.;emrK
emrK.3000206.D78168.536_1592.173	emrK.3000206.D78168.536_1592.173	1	0	539	232	emrK	1056	1056	98.2	emrK.l15.c30.ctg.1	1193	9.5	0	.	p	.	0	N306D	NONSYN	916	918	AAC	1021	1023	GAC	3;3;3	G;A;C	3;3;3	.	emrK is a membrane fusion protein that is a homolog of EmrA. Together with the inner membrane transporter EmrY and the outer membrane channel TolC, it mediates multidrug efflux.;emrK
emrR.3000516.NC_000913.3.2810769_2811300.3621	emrR.3000516.NC_000913.3.2810769_2811300.3621	1	0	27	168	emrR	531	531	100.0	emrR.l15.c30.ctg.1	938	9.5	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	EmrR is a negative regulator for the EmrAB-TolC multidrug efflux pump in E. coli. Mutations lead to EmrAB-TolC overexpression.;emrR
emrY.3000254.D78168.1591_3130.65	emrY.3000254.D78168.1591_3130.65	1	0	27	444	emrY	1539	1539	99.81	emrY.l15.c4.ctg.1	1948	12.2	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	emrY is a multidrug transport that moves substrates across the inner membrane of the Gram-negative E. coli. It is a homolog of emrB.;emrY
evgA.3000832.NC_002695.3211891_3212506.208	evgA.3000832.NC_002695.3211891_3212506.208	1	0	539	194	evgA	615	615	99.19	evgA.l15.c4.ctg.1	774	12.2	0	.	p	.	0	Q62L	NONSYN	184	186	CAG	277	279	CTG	10;10;11	C;T;G	10;10;11	.	EvgA, when phosphorylated, is a positive regulator for efflux protein complexes emrKY and mdtEF. While usually phosphorylated in a EvgS dependent manner, it can be phosphorylated in the absence of EvgS when overexpressed.;evgA
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	513	902	evgS	3594	1334	96.78	evgS.l15.c4.ctg.1	1337	13.4	0	.	p	.	0	Q433K	NONSYN	1297	1299	CAG	196	198	AAA	8;9;8	A;A;A	8;9;8	.	EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.;evgS
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	513	902	evgS	3594	1334	96.78	evgS.l15.c4.ctg.1	1337	13.4	0	.	p	.	0	N678H	NONSYN	2032	2034	AAT	931	933	CAT	16;16;16	C;A;T	16;16;16	.	EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.;evgS
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	513	902	evgS	3594	1334	96.78	evgS.l15.c4.ctg.1	1337	13.4	0	.	p	.	0	N696H	NONSYN	2086	2088	AAT	985	987	CAT	10;10;10	C;A;T	10;10;10	.	EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.;evgS
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	513	902	evgS	3594	1334	96.78	evgS.l15.c4.ctg.1	1337	13.4	0	.	p	.	0	K702R	NONSYN	2104	2106	AAA	1003	1005	AGA	10;10;10	A;G;A	10;10;10	.	EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.;evgS
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	513	902	evgS	3594	1334	96.78	evgS.l15.c4.ctg.1	1337	13.4	0	.	p	.	0	K707N	NONSYN	2119	2121	AAG	1018	1020	AAT	9;9;9	A;A;T	9;9;9	.	EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.;evgS
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	513	902	evgS	3594	1334	96.78	evgS.l15.c4.ctg.1	1337	13.4	0	.	p	.	0	A756S	NONSYN	2266	2268	GCC	1165	1167	TCC	6;5;4	T;C;C	6;5;4	.	EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.;evgS
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	513	902	evgS	3594	1334	96.78	evgS.l15.c4.ctg.1	1337	13.4	0	.	p	.	0	Q759K	NONSYN	2275	2277	CAA	1174	1176	AAA	3;3;3	A,C;A;A	1,2;3;3	.	EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.;evgS
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	513	902	evgS	3594	1334	96.78	evgS.l15.c4.ctg.1	1337	13.4	0	.	p	.	0	S811I	NONSYN	2431	2433	AGT	1330	1332	ATT	2;2;2	A;T;T	2;2;2	.	EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.;evgS
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	513	902	evgS	3594	1159	99.14	evgS.l15.c4.ctg.2	1248	14.6	0	.	p	.	0	E818D	NONSYN	2452	2454	GAA	17	19	GAT	6;6;8	G;A;T	6;6;8	.	EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.;evgS
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	513	902	evgS	3594	1159	99.14	evgS.l15.c4.ctg.2	1248	14.6	0	.	p	.	0	G856V	NONSYN	2566	2568	GGT	131	133	GTT	20;20;20	G;T;T	20;20;20	.	EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.;evgS
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	513	902	evgS	3594	1159	99.14	evgS.l15.c4.ctg.2	1248	14.6	0	.	p	.	0	Q951H	NONSYN	2851	2853	CAA	416	418	CAC	9;8;9	C;A;C	9;8;9	.	EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.;evgS
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	513	902	evgS	3594	458	97.82	evgS.l15.c4.ctg.3	469	11.8	0	.	p	.	0	I251V	NONSYN	751	753	ATT	138	140	GTT	15;15;15	G;T;T	15;15;15	.	EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.;evgS
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	513	902	evgS	3594	458	97.82	evgS.l15.c4.ctg.3	469	11.8	0	.	p	.	0	N303D	NONSYN	907	909	AAT	294	296	GAT	5;5;5	G;A;T	5;5;5	.	EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.;evgS
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	513	902	evgS	3594	204	95.59	evgS.l15.c4.ctg.5	204	7.9	0	.	p	.	0	P162S	NONSYN	484	486	CCA	67	69	TCA	7;7;7	T;C;A	7;7;7	.	EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.;evgS
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	513	902	evgS	3594	204	95.59	evgS.l15.c4.ctg.5	204	7.9	0	.	p	.	0	H205Q	NONSYN	613	615	CAC	196	198	CAG	2;2;2	C;A;G	2;2;2	.	EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.;evgS
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	513	902	evgS	3594	420	97.62	evgS.l15.c4.ctg.6	644	6.9	0	.	p	.	0	T38I	NONSYN	112	114	ACA	334	336	ATA	5;3;3	A;T;A	5;3;3	.	EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.;evgS
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	513	902	evgS	3594	420	97.62	evgS.l15.c4.ctg.6	644	6.9	0	.	p	.	0	L42V	NONSYN	124	126	CTA	346	348	GTA	1;1;1	G;T;A	1;1;1	.	EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.;evgS
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	513	902	evgS	3594	420	97.62	evgS.l15.c4.ctg.6	644	6.9	0	.	p	.	0	A93T	NONSYN	277	279	GCG	499	501	ACG	9;9;9	A;C;G	9;9;9	.	EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.;evgS
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	513	902	evgS	3594	420	97.62	evgS.l15.c4.ctg.6	644	6.9	0	.	p	.	0	A114E	NONSYN	340	342	GCA	562	564	GAA	3;3;3	G;A;A	3;3;3	.	EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.;evgS
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	513	902	evgS	3594	420	97.62	evgS.l15.c4.ctg.6	644	6.9	0	.	p	.	0	T127A	NONSYN	379	381	ACT	601	603	GCT	8;8;8	G;C;T	8;8;8	.	EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.;evgS
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	513	902	evgS	3594	420	97.62	evgS.l15.c4.ctg.6	644	6.9	0	.	p	.	0	N133D	NONSYN	397	399	AAT	619	621	GAT	6;5;5	G;A;T	6;5;5	.	EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.;evgS
folP.3003386.NC_007779.3323917_3324766.2056	folP.3003386.NC_007779.3323917_3324766.2056	1	1	539	268	folP_1	849	849	99.18	folP_1.l15.c4.ctg.1	1099	12.8	0	.	p	.	0	P123L	NONSYN	367	369	CCT	544	546	CTT	27;26;26	C;T;T	27;26;25	.	Escherichia coli sulfonamide resistant mutant folP
folP.3003386.NC_007779.3323917_3324766.2056	folP.3003386.NC_007779.3323917_3324766.2056	1	1	539	268	folP_1	849	849	99.18	folP_1.l15.c4.ctg.1	1099	12.8	1	SNP	p	P64A	0	.	.	190	192	CCA	367	369	CCA	18;18;18	C;C;A	18;18;18	folP.3003386.NC_007779.3323917_3324766.2056:1:1:P64A:.:Point mutations in Escherichia coli dihydropteroate synthase folP prevent sulfonamide antibiotics from inhibiting its role in folate synthesis, thus conferring sulfonamide resistance.	Escherichia coli sulfonamide resistant mutant folP
folP.3003386.NC_007779.3323917_3324766.2056	folP.3003386.NC_007779.3323917_3324766.2056	1	1	539	268	folP_1	849	849	99.18	folP_1.l15.c4.ctg.1	1099	12.8	1	SNP	p	P64S	0	.	.	190	192	CCA	367	369	CCA	18;18;18	C;C;A	18;18;18	folP.3003386.NC_007779.3323917_3324766.2056:1:1:P64S:.:Point mutations in Escherichia coli dihydropteroate synthase folP prevent sulfonamide antibiotics from inhibiting its role in folate synthesis, thus conferring sulfonamide resistance.	Escherichia coli sulfonamide resistant mutant folP
folP.3003386.NC_007779.3323917_3324766.2056	folP.3003386.NC_007779.3323917_3324766.2056	1	1	539	268	folP_1	849	849	99.18	folP_1.l15.c4.ctg.1	1099	12.8	1	SNP	p	P64L	0	.	.	190	192	CCA	367	369	CCA	18;18;18	C;C;A	18;18;18	folP.3003386.NC_007779.3323917_3324766.2056:1:1:P64L:.:Point mutations in Escherichia coli dihydropteroate synthase folP prevent sulfonamide antibiotics from inhibiting its role in folate synthesis, thus conferring sulfonamide resistance.	Escherichia coli sulfonamide resistant mutant folP
folP.3003386.NC_007779.3323917_3324766.2056	folP.3003386.NC_007779.3323917_3324766.2056	1	1	539	268	folP_1	849	849	99.18	folP_1.l15.c4.ctg.1	1099	12.8	1	SNP	p	P64H	0	.	.	190	192	CCA	367	369	CCA	18;18;18	C;C;A	18;18;18	folP.3003386.NC_007779.3323917_3324766.2056:1:1:P64H:.:Point mutations in Escherichia coli dihydropteroate synthase folP prevent sulfonamide antibiotics from inhibiting its role in folate synthesis, thus conferring sulfonamide resistance.	Escherichia coli sulfonamide resistant mutant folP
folP.3003386.NC_007779.3323917_3324766.2056	folP.3003386.NC_007779.3323917_3324766.2056	1	1	539	268	folP_1	849	849	99.18	folP_1.l15.c4.ctg.1	1099	12.8	1	SNP	p	P64R	0	.	.	190	192	CCA	367	369	CCA	18;18;18	C;C;A	18;18;18	folP.3003386.NC_007779.3323917_3324766.2056:1:1:P64R:.:Point mutations in Escherichia coli dihydropteroate synthase folP prevent sulfonamide antibiotics from inhibiting its role in folate synthesis, thus conferring sulfonamide resistance.	Escherichia coli sulfonamide resistant mutant folP
gadE.3003834.NC_000913.3.3658365_3658893.3597	gadE.3003834.NC_000913.3.3658365_3658893.3597	1	0	27	230	gadE	528	528	100.0	gadE.l15.c30.ctg.1	969	12.7	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	gadE;gadE is a DNA-binding transcriptional activator that regulates the expression of genes involved in acid resistance. It is required for the expression of gadA and gadBC.
gadW.3003838.CP015085.1.2551711_2552440.3599	gadW.3003838.CP015085.1.2551711_2552440.3599	1	0	16	58	gadW	729	143	97.2	gadW.l15.c17.ctg.1	143	9.1	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	GadW is an AraC-family regulator that promotes mdtEF expression to confer multidrug resistance. GadW inhibits GadX-dependent activation. GadW clearly represses gadX and, in situations where GadX is missing, activates gadA and gadBC.;gadW
gadX.3000508.NC_007779.3974604_3975429.615	gadX.3000508.NC_007779.3974604_3975429.615	1	0	531	210	gadX	825	812	98.03	gadX.l15.c4.ctg.1	874	11.9	0	.	p	.	0	F53L	NONSYN	157	159	TTC	144	146	TTA	15;16;16	T;T;A	15;16;16	.	GadX is an AraC-family regulator that promotes mdtEF expression to confer multidrug resistance.;gadX
gadX.3000508.NC_007779.3974604_3975429.615	gadX.3000508.NC_007779.3974604_3975429.615	1	0	531	210	gadX	825	812	98.03	gadX.l15.c4.ctg.1	874	11.9	0	.	p	.	0	V79I	NONSYN	235	237	GTT	222	224	ATT	11;12;11	A;T;T	11;12;11	.	GadX is an AraC-family regulator that promotes mdtEF expression to confer multidrug resistance.;gadX
gadX.3000508.NC_007779.3974604_3975429.615	gadX.3000508.NC_007779.3974604_3975429.615	1	0	531	210	gadX	825	812	98.03	gadX.l15.c4.ctg.1	874	11.9	0	.	p	.	0	R246G	NONSYN	736	738	AGA	723	725	GGA	6;6;6	G;G;A	6;6;5	.	GadX is an AraC-family regulator that promotes mdtEF expression to confer multidrug resistance.;gadX
gadX.3000508.NC_007779.3974604_3975429.615	gadX.3000508.NC_007779.3974604_3975429.615	1	0	531	210	gadX	825	812	98.03	gadX.l15.c4.ctg.1	874	11.9	0	.	p	.	0	S248P	NONSYN	742	744	TCG	729	731	CCG	7;7;8	C;C;G	7;7;8	.	GadX is an AraC-family regulator that promotes mdtEF expression to confer multidrug resistance.;gadX
gyrA.3003294.U00096.2336792_2339420.2052	gyrA.3003294.U00096.2336792_2339420.2052	1	1	539	740	gyrA_7	2628	2628	98.71	gyrA_7.l15.c30.ctg.1	2877	13.6	0	.	p	.	0	D678E	NONSYN	2032	2034	GAC	2100	2102	GAA	13;13;13	G;A;A	13;13;13	.	Escherichia coli gyrA conferring resistance to fluoroquinolones
gyrA.3003294.U00096.2336792_2339420.2052	gyrA.3003294.U00096.2336792_2339420.2052	1	1	539	740	gyrA_7	2628	2628	98.71	gyrA_7.l15.c30.ctg.1	2877	13.6	1	SNP	p	S83W	0	.	.	247	249	TCG	315	317	TCG	8;8;7	T;C;G	8;8;7	gyrA.3003294.U00096.2336792_2339420.2052:1:1:S83W:.:Point mutation of Escherichia coli gyrA resulted in the lowered affinity between fluoroquinolones and gyrA. Thus, conferring resistance	Escherichia coli gyrA conferring resistance to fluoroquinolones
gyrA.3003294.U00096.2336792_2339420.2052	gyrA.3003294.U00096.2336792_2339420.2052	1	1	539	740	gyrA_7	2628	2628	98.71	gyrA_7.l15.c30.ctg.1	2877	13.6	1	SNP	p	S83I	0	.	.	247	249	TCG	315	317	TCG	8;8;7	T;C;G	8;8;7	gyrA.3003294.U00096.2336792_2339420.2052:1:1:S83I:.:Point mutation of Escherichia coli gyrA resulted in the lowered affinity between fluoroquinolones and gyrA. Thus, conferring resistance	Escherichia coli gyrA conferring resistance to fluoroquinolones
gyrA.3003294.U00096.2336792_2339420.2052	gyrA.3003294.U00096.2336792_2339420.2052	1	1	539	740	gyrA_7	2628	2628	98.71	gyrA_7.l15.c30.ctg.1	2877	13.6	1	SNP	p	S83L	0	.	.	247	249	TCG	315	317	TCG	8;8;7	T;C;G	8;8;7	gyrA.3003294.U00096.2336792_2339420.2052:1:1:S83L:.:Point mutation of Escherichia coli gyrA resulted in the lowered affinity between fluoroquinolones and gyrA. Thus, conferring resistance	Escherichia coli gyrA conferring resistance to fluoroquinolones
gyrA.3003294.U00096.2336792_2339420.2052	gyrA.3003294.U00096.2336792_2339420.2052	1	1	539	740	gyrA_7	2628	2628	98.71	gyrA_7.l15.c30.ctg.1	2877	13.6	1	SNP	p	D87H	0	.	.	259	261	GAC	327	329	GAC	9;9;9	G;A;C	9;9;9	gyrA.3003294.U00096.2336792_2339420.2052:1:1:D87H:.:Point mutation of Escherichia coli gyrA resulted in the lowered affinity between fluoroquinolones and gyrA. Thus, conferring resistance	Escherichia coli gyrA conferring resistance to fluoroquinolones
gyrA.3003294.U00096.2336792_2339420.2052	gyrA.3003294.U00096.2336792_2339420.2052	1	1	539	740	gyrA_7	2628	2628	98.71	gyrA_7.l15.c30.ctg.1	2877	13.6	1	SNP	p	D87N	0	.	.	259	261	GAC	327	329	GAC	9;9;9	G;A;C	9;9;9	gyrA.3003294.U00096.2336792_2339420.2052:1:1:D87N:.:Point mutation of Escherichia coli gyrA resulted in the lowered affinity between fluoroquinolones and gyrA. Thus, conferring resistance	Escherichia coli gyrA conferring resistance to fluoroquinolones
gyrA.3003294.U00096.2336792_2339420.2052	gyrA.3003294.U00096.2336792_2339420.2052	1	1	539	740	gyrA_7	2628	2628	98.71	gyrA_7.l15.c30.ctg.1	2877	13.6	1	SNP	p	D87G	0	.	.	259	261	GAC	327	329	GAC	9;9;9	G;A;C	9;9;9	gyrA.3003294.U00096.2336792_2339420.2052:1:1:D87G:.:Point mutation of Escherichia coli gyrA resulted in the lowered affinity between fluoroquinolones and gyrA. Thus, conferring resistance	Escherichia coli gyrA conferring resistance to fluoroquinolones
gyrA.3003294.U00096.2336792_2339420.2052	gyrA.3003294.U00096.2336792_2339420.2052	1	1	539	740	gyrA_7	2628	2628	98.71	gyrA_7.l15.c30.ctg.1	2877	13.6	1	SNP	p	D87V	0	.	.	259	261	GAC	327	329	GAC	9;9;9	G;A;C	9;9;9	gyrA.3003294.U00096.2336792_2339420.2052:1:1:D87V:.:Point mutation of Escherichia coli gyrA resulted in the lowered affinity between fluoroquinolones and gyrA. Thus, conferring resistance	Escherichia coli gyrA conferring resistance to fluoroquinolones
gyrA.3003294.U00096.2336792_2339420.2052	gyrA.3003294.U00096.2336792_2339420.2052	1	1	539	740	gyrA_7	2628	2628	98.71	gyrA_7.l15.c30.ctg.1	2877	13.6	1	SNP	p	D87Y	0	.	.	259	261	GAC	327	329	GAC	9;9;9	G;A;C	9;9;9	gyrA.3003294.U00096.2336792_2339420.2052:1:1:D87Y:.:Point mutation of Escherichia coli gyrA resulted in the lowered affinity between fluoroquinolones and gyrA. Thus, conferring resistance	Escherichia coli gyrA conferring resistance to fluoroquinolones
gyrB.3003303.AP009048.3760295_3762710.2063	gyrB.3003303.AP009048.3760295_3762710.2063	1	1	27	722	gyrB_1	2415	2415	99.13	gyrB_1.l15.c30.ctg.1	2642	14.2	1	SNP	p	R136L	0	.	.	406	408	CGC	614	616	CGC	12;10;10	C;G;C	12;10;10	gyrB.3003303.AP009048.3760295_3762710.2063:1:1:R136L:.:Point mutation in Escherichia coli resulting in aminocoumarin resistance	Escherichia coli gyrB conferring resistance to aminocoumarin
gyrB.3003303.AP009048.3760295_3762710.2063	gyrB.3003303.AP009048.3760295_3762710.2063	1	1	27	722	gyrB_1	2415	2415	99.13	gyrB_1.l15.c30.ctg.1	2642	14.2	1	SNP	p	R136G	0	.	.	406	408	CGC	614	616	CGC	12;10;10	C;G;C	12;10;10	gyrB.3003303.AP009048.3760295_3762710.2063:1:1:R136G:.:Point mutation in Escherichia coli resulting in aminocoumarin resistance	Escherichia coli gyrB conferring resistance to aminocoumarin
gyrB.3003303.AP009048.3760295_3762710.2063	gyrB.3003303.AP009048.3760295_3762710.2063	1	1	27	722	gyrB_1	2415	2415	99.13	gyrB_1.l15.c30.ctg.1	2642	14.2	1	SNP	p	R136H	0	.	.	406	408	CGC	614	616	CGC	12;10;10	C;G;C	12;10;10	gyrB.3003303.AP009048.3760295_3762710.2063:1:1:R136H:.:Point mutation in Escherichia coli resulting in aminocoumarin resistance	Escherichia coli gyrB conferring resistance to aminocoumarin
gyrB.3003303.AP009048.3760295_3762710.2063	gyrB.3003303.AP009048.3760295_3762710.2063	1	1	27	722	gyrB_1	2415	2415	99.13	gyrB_1.l15.c30.ctg.1	2642	14.2	1	SNP	p	R136C	0	.	.	406	408	CGC	614	616	CGC	12;10;10	C;G;C	12;10;10	gyrB.3003303.AP009048.3760295_3762710.2063:1:1:R136C:.:Point mutation in Escherichia coli resulting in aminocoumarin resistance	Escherichia coli gyrB conferring resistance to aminocoumarin
gyrB.3003303.AP009048.3760295_3762710.2063	gyrB.3003303.AP009048.3760295_3762710.2063	1	1	27	722	gyrB_1	2415	2415	99.13	gyrB_1.l15.c30.ctg.1	2642	14.2	1	SNP	p	R136E	0	.	.	406	408	CGC	614	616	CGC	12;10;10	C;G;C	12;10;10	gyrB.3003303.AP009048.3760295_3762710.2063:1:1:R136E:.:Point mutation in Escherichia coli resulting in aminocoumarin resistance	Escherichia coli gyrB conferring resistance to aminocoumarin
gyrB.3003303.AP009048.3760295_3762710.2063	gyrB.3003303.AP009048.3760295_3762710.2063	1	1	27	722	gyrB_1	2415	2415	99.13	gyrB_1.l15.c30.ctg.1	2642	14.2	1	SNP	p	R136S	0	.	.	406	408	CGC	614	616	CGC	12;10;10	C;G;C	12;10;10	gyrB.3003303.AP009048.3760295_3762710.2063:1:1:R136S:.:Point mutation in Escherichia coli resulting in aminocoumarin resistance	Escherichia coli gyrB conferring resistance to aminocoumarin
gyrB.3003303.AP009048.3760295_3762710.2063	gyrB.3003303.AP009048.3760295_3762710.2063	1	1	27	722	gyrB_1	2415	2415	99.13	gyrB_1.l15.c30.ctg.1	2642	14.2	1	SNP	p	R136I	0	.	.	406	408	CGC	614	616	CGC	12;10;10	C;G;C	12;10;10	gyrB.3003303.AP009048.3760295_3762710.2063:1:1:R136I:.:Point mutation in Escherichia coli resulting in aminocoumarin resistance	Escherichia coli gyrB conferring resistance to aminocoumarin
kdpE.3003841.NC_000913.3.721055_721733.3608	kdpE.3003841.NC_000913.3.721055_721733.3608	1	0	539	200	kdpE	678	678	98.08	kdpE.l15.c17.ctg.1	923	11.4	0	.	p	.	0	A72P	NONSYN	214	216	GCG	363	365	CCG	14;14;15	C;C;G	14;14;15	.	kdpE is a transcriptional activator that is part of the two-component system KdpD/KdpE that is studied for its regulatory role in potassium transport and has been identified as an adaptive regulator involved in the virulence and intracellular survival of pathogenic bacteria. kdpE regulates a range of virulence loci through direct promoter binding.;kdpE
kdpE.3003841.NC_000913.3.721055_721733.3608	kdpE.3003841.NC_000913.3.721055_721733.3608	1	0	539	200	kdpE	678	678	98.08	kdpE.l15.c17.ctg.1	923	11.4	0	.	p	.	0	T123A	NONSYN	367	369	ACC	516	518	GCC	16;16;16	G;C;C	16;16;16	.	kdpE is a transcriptional activator that is part of the two-component system KdpD/KdpE that is studied for its regulatory role in potassium transport and has been identified as an adaptive regulator involved in the virulence and intracellular survival of pathogenic bacteria. kdpE regulates a range of virulence loci through direct promoter binding.;kdpE
leuO.3003843.NC_000913.3.84367_85312.3607	leuO.3003843.NC_000913.3.84367_85312.3607	1	0	539	324	leuO	945	945	99.26	leuO.l6.c4.ctg.1	1302	13.3	0	.	p	.	0	P9S	NONSYN	25	27	CCA	162	164	TCA	10;11;11	T;C;A	10;11;11	.	leuO;leuO, a LysR family transcription factor, exists in a wide variety of bacteria of the family Enterobacteriaceae and is involved in the regulation of as yet unidentified genes affecting the stress response and pathogenesis expression.
marA.3000263.NC_007779.1621287_1621671.579	marA.3000263.NC_007779.1621287_1621671.579	1	0	19	96	marA	384	371	100.0	marA.l15.c4.ctg.1	583	7.1	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	In the presence of antibiotic stress, E. coli overexpresses the global activator protein MarA, which besides inducing MDR efflux pump AcrAB, also down- regulates synthesis of the porin OmpF.;marA
marR.3003378.U00096.1619119_1619554.2097	marR.3003378.U00096.1619119_1619554.2097	1	1	531	80	marR	435	419	97.61	marR.l15.c30.ctg.1	607	6.6	1	SNP	p	G103S	1	G103S	NONSYN	307	309	GGC	495	497	AGC	5;6;6	A;G;C	5;6;6	marR.3003378.U00096.1619119_1619554.2097:1:1:G103S:.:MarR is a repressor of the mar operon marRAB, thus regulating the expression of marA, the activator of multidrug efflux pump AcrAB.	Escherichia coli marR mutant conferring antibiotic resistance
marR.3003378.U00096.1619119_1619554.2097	marR.3003378.U00096.1619119_1619554.2097	1	1	531	80	marR	435	419	97.61	marR.l15.c30.ctg.1	607	6.6	1	SNP	p	Y137H	1	Y137H	NONSYN	409	411	TAT	597	599	CAT	4;3;3	C;A;T	2;1;3	marR.3003378.U00096.1619119_1619554.2097:1:1:Y137H:.:MarR is a repressor of the mar operon marRAB, thus regulating the expression of marA, the activator of multidrug efflux pump AcrAB.	Escherichia coli marR mutant conferring antibiotic resistance
marR.3003378.U00096.1619119_1619554.2097	marR.3003378.U00096.1619119_1619554.2097	1	1	531	80	marR	435	419	97.61	marR.l15.c30.ctg.1	607	6.6	1	SNP	p	V45E	0	.	.	133	135	GTG	321	323	GTG	10;10;10	G;T;G	10;9;10	marR.3003378.U00096.1619119_1619554.2097:1:1:V45E:.:MarR is a repressor of the mar operon marRAB, thus regulating the expression of marA, the activator of multidrug efflux pump AcrAB.	Escherichia coli marR mutant conferring antibiotic resistance
marR.3003378.U00096.1619119_1619554.2097	marR.3003378.U00096.1619119_1619554.2097	1	1	531	80	marR	435	419	97.61	marR.l15.c30.ctg.1	607	6.6	1	SNP	p	I49S	0	.	.	145	147	ATC	333	335	ATC	10;11;11	A;T;C	10;11;11	marR.3003378.U00096.1619119_1619554.2097:1:1:I49S:.:MarR is a repressor of the mar operon marRAB, thus regulating the expression of marA, the activator of multidrug efflux pump AcrAB.	Escherichia coli marR mutant conferring antibiotic resistance
marR.3003378.U00096.1619119_1619554.2097	marR.3003378.U00096.1619119_1619554.2097	1	1	531	80	marR	435	419	97.61	marR.l15.c30.ctg.1	607	6.6	1	SNP	p	A70T	0	.	.	208	210	GCA	396	398	GCA	10;10;10	G;C;A	10;10;10	marR.3003378.U00096.1619119_1619554.2097:1:1:A70T:.:MarR is a repressor of the mar operon marRAB, thus regulating the expression of marA, the activator of multidrug efflux pump AcrAB.	Escherichia coli marR mutant conferring antibiotic resistance
marR.3003378.U00096.1619119_1619554.2097	marR.3003378.U00096.1619119_1619554.2097	1	1	531	80	marR	435	419	97.61	marR.l15.c30.ctg.1	607	6.6	1	SNP	p	R73C	0	.	.	217	219	CGT	405	407	CGT	11;11;11	C;G;T	11;11;11	marR.3003378.U00096.1619119_1619554.2097:1:1:R73C:.:MarR is a repressor of the mar operon marRAB, thus regulating the expression of marA, the activator of multidrug efflux pump AcrAB.	Escherichia coli marR mutant conferring antibiotic resistance
marR.3003378.U00096.1619119_1619554.2097	marR.3003378.U00096.1619119_1619554.2097	1	1	531	80	marR	435	419	97.61	marR.l15.c30.ctg.1	607	6.6	1	SNP	p	R73S	0	.	.	217	219	CGT	405	407	CGT	11;11;11	C;G;T	11;11;11	marR.3003378.U00096.1619119_1619554.2097:1:1:R73S:.:MarR is a repressor of the mar operon marRAB, thus regulating the expression of marA, the activator of multidrug efflux pump AcrAB.	Escherichia coli marR mutant conferring antibiotic resistance
marR.3003378.U00096.1619119_1619554.2097	marR.3003378.U00096.1619119_1619554.2097	1	1	531	80	marR	435	419	97.61	marR.l15.c30.ctg.1	607	6.6	1	SNP	p	R77L	0	.	.	229	231	CGC	417	419	CGC	11;11;11	C;G;C	11;11;11	marR.3003378.U00096.1619119_1619554.2097:1:1:R77L:.:MarR is a repressor of the mar operon marRAB, thus regulating the expression of marA, the activator of multidrug efflux pump AcrAB.	Escherichia coli marR mutant conferring antibiotic resistance
marR.3003378.U00096.1619119_1619554.2097	marR.3003378.U00096.1619119_1619554.2097	1	1	531	80	marR	435	419	97.61	marR.l15.c30.ctg.1	607	6.6	1	SNP	p	R77C	0	.	.	229	231	CGC	417	419	CGC	11;11;11	C;G;C	11;11;11	marR.3003378.U00096.1619119_1619554.2097:1:1:R77C:.:MarR is a repressor of the mar operon marRAB, thus regulating the expression of marA, the activator of multidrug efflux pump AcrAB.	Escherichia coli marR mutant conferring antibiotic resistance
marR.3003378.U00096.1619119_1619554.2097	marR.3003378.U00096.1619119_1619554.2097	1	1	531	80	marR	435	419	97.61	marR.l15.c30.ctg.1	607	6.6	1	SNP	p	L78M	0	.	.	232	234	CTG	420	422	CTG	11;9;8	C;T;G	11;9;8	marR.3003378.U00096.1619119_1619554.2097:1:1:L78M:.:MarR is a repressor of the mar operon marRAB, thus regulating the expression of marA, the activator of multidrug efflux pump AcrAB.	Escherichia coli marR mutant conferring antibiotic resistance
marR.3003378.U00096.1619119_1619554.2097	marR.3003378.U00096.1619119_1619554.2097	1	1	531	80	marR	435	419	97.61	marR.l15.c30.ctg.1	607	6.6	1	SNP	p	R94H	0	.	.	280	282	CGC	468	470	CGC	4;4;4	C;G;C	3;4;4	marR.3003378.U00096.1619119_1619554.2097:1:1:R94H:.:MarR is a repressor of the mar operon marRAB, thus regulating the expression of marA, the activator of multidrug efflux pump AcrAB.	Escherichia coli marR mutant conferring antibiotic resistance
marR.3003378.U00096.1619119_1619554.2097	marR.3003378.U00096.1619119_1619554.2097	1	1	531	80	marR	435	419	97.61	marR.l15.c30.ctg.1	607	6.6	1	SNP	p	R94S	0	.	.	280	282	CGC	468	470	CGC	4;4;4	C;G;C	3;4;4	marR.3003378.U00096.1619119_1619554.2097:1:1:R94S:.:MarR is a repressor of the mar operon marRAB, thus regulating the expression of marA, the activator of multidrug efflux pump AcrAB.	Escherichia coli marR mutant conferring antibiotic resistance
marR.3003378.U00096.1619119_1619554.2097	marR.3003378.U00096.1619119_1619554.2097	1	1	531	80	marR	435	419	97.61	marR.l15.c30.ctg.1	607	6.6	1	SNP	p	V96E	0	.	.	286	288	GTA	474	476	GTA	4;5;5	G;T;A	4;5;5	marR.3003378.U00096.1619119_1619554.2097:1:1:V96E:.:MarR is a repressor of the mar operon marRAB, thus regulating the expression of marA, the activator of multidrug efflux pump AcrAB.	Escherichia coli marR mutant conferring antibiotic resistance
mdfA.3001328.JQ394987.0_1233.561	mdfA.3001328.JQ394987.0_1233.561	1	0	513	204	mdfA	1233	1019	97.55	mdfA.l6.c4.ctg.1	1014	9.2	0	.	p	.	0	H115Q	NONSYN	343	345	CAC	134	136	CAG	10;10;10	C;A;G	10;10;10	.	mdfA;Multidrug translocase MdfA
mdfA.3001328.JQ394987.0_1233.561	mdfA.3001328.JQ394987.0_1233.561	1	0	513	204	mdfA	1233	1019	97.55	mdfA.l6.c4.ctg.1	1014	9.2	0	.	p	.	0	D128A	NONSYN	382	384	GAC	173	175	GCC	5;5;6	G;C;C	5;5;6	.	mdfA;Multidrug translocase MdfA
mdfA.3001328.JQ394987.0_1233.561	mdfA.3001328.JQ394987.0_1233.561	1	0	513	204	mdfA	1233	1019	97.55	mdfA.l6.c4.ctg.1	1014	9.2	0	.	p	.	0	S163A	NONSYN	487	489	TCG	278	280	GCG	5;5;5	G;C;G	5;5;5	.	mdfA;Multidrug translocase MdfA
mdfA.3001328.JQ394987.0_1233.561	mdfA.3001328.JQ394987.0_1233.561	1	0	513	204	mdfA	1233	1019	97.55	mdfA.l6.c4.ctg.1	1014	9.2	0	.	p	.	0	L231V	NONSYN	691	693	CTT	482	484	GTT	6;6;7	G;T;T	4;6;6	.	mdfA;Multidrug translocase MdfA
mdfA.3001328.JQ394987.0_1233.561	mdfA.3001328.JQ394987.0_1233.561	1	0	513	204	mdfA	1233	1019	97.55	mdfA.l6.c4.ctg.1	1014	9.2	0	.	p	.	0	R285fs	FSHIFT	853	853	C	644	644	C	4	C	4	.	mdfA;Multidrug translocase MdfA
mdfA.3001328.JQ394987.0_1233.561	mdfA.3001328.JQ394987.0_1233.561	1	0	513	204	mdfA	1233	172	94.19	mdfA.l6.c4.ctg.3	175	4.6	0	.	p	.	0	R36I	NONSYN	106	108	AGG	89	91	ATC	9;9;9	A;T;C	9;9;9	.	mdfA;Multidrug translocase MdfA
mdfA.3001328.JQ394987.0_1233.561	mdfA.3001328.JQ394987.0_1233.561	1	0	513	204	mdfA	1233	172	94.19	mdfA.l6.c4.ctg.3	175	4.6	0	.	p	.	0	E42A	NONSYN	124	126	GAA	107	109	GCC	3;3;3	G;C;C	3;3;3	.	mdfA;Multidrug translocase MdfA
mdfA.3001328.JQ394987.0_1233.561	mdfA.3001328.JQ394987.0_1233.561	1	0	513	204	mdfA	1233	172	94.19	mdfA.l6.c4.ctg.3	175	4.6	0	.	p	.	0	N43V	NONSYN	127	129	AAT	110	112	GTG	2;2;2	G;T;G	2;2;2	.	mdfA;Multidrug translocase MdfA
mdfA.3001328.JQ394987.0_1233.561	mdfA.3001328.JQ394987.0_1233.561	1	0	513	204	mdfA	1233	172	94.19	mdfA.l6.c4.ctg.3	175	4.6	0	.	p	.	0	E52D	NONSYN	154	156	GAG	137	139	GAT	3;3;3	G;A;T	3;3;3	.	mdfA;Multidrug translocase MdfA
mdfA.3001328.JQ394987.0_1233.561	mdfA.3001328.JQ394987.0_1233.561	1	0	513	204	mdfA	1233	172	94.19	mdfA.l6.c4.ctg.3	175	4.6	0	.	p	.	0	N59T	NONSYN	175	177	AAC	158	160	ACC	2;2;2	A;C;C	2;2;2	.	mdfA;Multidrug translocase MdfA
mdtA.3000792.U00096.2154015_2155263.15	mdtA.3000792.U00096.2154015_2155263.15	1	0	539	708	mdtA	1248	1248	97.44	mdtA.l15.c17.ctg.1	1618	23.3	0	.	p	.	0	V12trunc	TRUNC	34	34	G	231	231	G	24	G	24	.	MdtA is the membrane fusion protein of the multidrug efflux complex mdtABC.;mdtA
mdtA.3000792.U00096.2154015_2155263.15	mdtA.3000792.U00096.2154015_2155263.15	1	0	539	708	mdtA	1248	1248	97.44	mdtA.l15.c17.ctg.1	1618	23.3	0	.	p	.	0	R33Q	NONSYN	97	99	CGG	288	290	CAG	14;14;14	C;A;G	14;13;14	.	MdtA is the membrane fusion protein of the multidrug efflux complex mdtABC.;mdtA
mdtA.3000792.U00096.2154015_2155263.15	mdtA.3000792.U00096.2154015_2155263.15	1	0	539	708	mdtA	1248	1248	97.44	mdtA.l15.c17.ctg.1	1618	23.3	0	.	p	.	0	T83I	NONSYN	247	249	ACC	438	440	ATC	13;12;11	A;T;C	13;12;11	.	MdtA is the membrane fusion protein of the multidrug efflux complex mdtABC.;mdtA
mdtA.3000792.U00096.2154015_2155263.15	mdtA.3000792.U00096.2154015_2155263.15	1	0	539	708	mdtA	1248	1248	97.44	mdtA.l15.c17.ctg.1	1618	23.3	0	.	p	.	0	I99M	NONSYN	295	297	ATA	486	488	ATG	8;10;11	A;T;G	8;9;11	.	MdtA is the membrane fusion protein of the multidrug efflux complex mdtABC.;mdtA
mdtA.3000792.U00096.2154015_2155263.15	mdtA.3000792.U00096.2154015_2155263.15	1	0	539	708	mdtA	1248	1248	97.44	mdtA.l15.c17.ctg.1	1618	23.3	0	.	p	.	0	A130T	NONSYN	388	390	GCC	579	581	ACC	17;17;17	A;C;C	17;17;17	.	MdtA is the membrane fusion protein of the multidrug efflux complex mdtABC.;mdtA
mdtB.3000793.U00096.2155262_2158385.215	mdtB.3000793.U00096.2155262_2158385.215	1	0	539	2402	mdtB	3123	3123	98.91	mdtB.l6.c30.ctg.1	3673	35.1	0	.	p	.	0	A306S	NONSYN	916	918	GCC	1218	1220	TCC	44;42;40	T;C;C	41;42;40	.	mdtB;MdtB is a transporter that forms a heteromultimer complex with MdtC to form a multidrug transporter. MdtBC is part of the MdtABC-TolC efflux complex.
mdtB.3000793.U00096.2155262_2158385.215	mdtB.3000793.U00096.2155262_2158385.215	1	0	539	2402	mdtB	3123	3123	98.91	mdtB.l6.c30.ctg.1	3673	35.1	0	.	p	.	0	A583T	NONSYN	1747	1749	GCC	2049	2051	ACC	39;38;38	A;C;C	39;38;38	.	mdtB;MdtB is a transporter that forms a heteromultimer complex with MdtC to form a multidrug transporter. MdtBC is part of the MdtABC-TolC efflux complex.
mdtB.3000793.U00096.2155262_2158385.215	mdtB.3000793.U00096.2155262_2158385.215	1	0	539	2402	mdtB	3123	3123	98.91	mdtB.l6.c30.ctg.1	3673	35.1	0	.	p	.	0	K714Q	NONSYN	2140	2142	AAA	2442	2444	CAA	25;26;27	C;A;A	25;26;27	.	mdtB;MdtB is a transporter that forms a heteromultimer complex with MdtC to form a multidrug transporter. MdtBC is part of the MdtABC-TolC efflux complex.
mdtB.3000793.U00096.2155262_2158385.215	mdtB.3000793.U00096.2155262_2158385.215	1	0	539	2402	mdtB	3123	3123	98.91	mdtB.l6.c30.ctg.1	3673	35.1	0	.	p	.	0	N770I	NONSYN	2308	2310	AAT	2610	2612	ATT	28;28;26	A;T;T	28;28;26	.	mdtB;MdtB is a transporter that forms a heteromultimer complex with MdtC to form a multidrug transporter. MdtBC is part of the MdtABC-TolC efflux complex.
mdtB.3000793.U00096.2155262_2158385.215	mdtB.3000793.U00096.2155262_2158385.215	1	0	539	2402	mdtB	3123	3123	98.91	mdtB.l6.c30.ctg.1	3673	35.1	0	.	p	.	0	I798V	NONSYN	2392	2394	ATT	2694	2696	GTT	35;35;36	G;T;T	35;35;36	.	mdtB;MdtB is a transporter that forms a heteromultimer complex with MdtC to form a multidrug transporter. MdtBC is part of the MdtABC-TolC efflux complex.
mdtB.3000793.U00096.2155262_2158385.215	mdtB.3000793.U00096.2155262_2158385.215	1	0	539	2402	mdtB	3123	3123	98.91	mdtB.l6.c30.ctg.1	3673	35.1	0	.	p	.	0	A834E	NONSYN	2500	2502	GCG	2802	2804	GAG	19;19;19	G;A;G	19;19;19	.	mdtB;MdtB is a transporter that forms a heteromultimer complex with MdtC to form a multidrug transporter. MdtBC is part of the MdtABC-TolC efflux complex.
mdtB.3000793.U00096.2155262_2158385.215	mdtB.3000793.U00096.2155262_2158385.215	1	0	539	2402	mdtB	3123	3123	98.91	mdtB.l6.c30.ctg.1	3673	35.1	0	.	p	.	0	L910M	NONSYN	2728	2730	CTG	3030	3032	ATG	20;18;18	A;T;G,T	20;18;17,1	.	mdtB;MdtB is a transporter that forms a heteromultimer complex with MdtC to form a multidrug transporter. MdtBC is part of the MdtABC-TolC efflux complex.
mdtB.3000793.U00096.2155262_2158385.215	mdtB.3000793.U00096.2155262_2158385.215	1	0	539	2402	mdtB	3123	3123	98.91	mdtB.l6.c30.ctg.1	3673	35.1	0	.	p	.	0	E955D	NONSYN	2863	2865	GAG	3165	3167	GAT	36;35;35	G;A;T	36;35;35	.	mdtB;MdtB is a transporter that forms a heteromultimer complex with MdtC to form a multidrug transporter. MdtBC is part of the MdtABC-TolC efflux complex.
mdtC.3000794.U00096.2158385_2161463.257	mdtC.3000794.U00096.2158385_2161463.257	1	0	539	2110	mdtC	3078	3078	98.7	mdtC.l15.c4.ctg.1	3298	33.6	0	.	p	.	0	I46M	NONSYN	136	138	ATC	335	337	ATG	28;27;29	A;T;G	28;26;29	.	MdtC is a transporter that forms a heteromultimer complex with MdtB to form a multidrug transporter. MdtBC is part of the MdtABC-TolC efflux complex. In the absence of MdtB, MdtC can form a homomultimer complex that results in a functioning efflux complex with a narrower drug specificity.;mdtC
mdtC.3000794.U00096.2158385_2161463.257	mdtC.3000794.U00096.2158385_2161463.257	1	0	539	2110	mdtC	3078	3078	98.7	mdtC.l15.c4.ctg.1	3298	33.6	0	.	p	.	0	V208I	NONSYN	622	624	GTC	821	823	ATC	28;27;28	A;T;C	27;27;26	.	MdtC is a transporter that forms a heteromultimer complex with MdtB to form a multidrug transporter. MdtBC is part of the MdtABC-TolC efflux complex. In the absence of MdtB, MdtC can form a homomultimer complex that results in a functioning efflux complex with a narrower drug specificity.;mdtC
mdtC.3000794.U00096.2158385_2161463.257	mdtC.3000794.U00096.2158385_2161463.257	1	0	539	2110	mdtC	3078	3078	98.7	mdtC.l15.c4.ctg.1	3298	33.6	0	.	p	.	0	Q980H	NONSYN	2938	2940	CAA	3137	3139	CAC	5;5;5	C;A;C	5;5;5	.	MdtC is a transporter that forms a heteromultimer complex with MdtB to form a multidrug transporter. MdtBC is part of the MdtABC-TolC efflux complex. In the absence of MdtB, MdtC can form a homomultimer complex that results in a functioning efflux complex with a narrower drug specificity.;mdtC
mdtD.3001330.U00096.2161463_2162879.299	mdtD.3001330.U00096.2161463_2162879.299	1	0	539	1184	mdtD	1416	1416	98.38	mdtD.l15.c4.ctg.1	1847	34.5	0	.	p	.	0	D3E	NONSYN	7	9	GAT	169	171	GAA	22;22;22	G;A;A	22;22;22	.	mdtD;Efflux pump mdtD
mdtD.3001330.U00096.2161463_2162879.299	mdtD.3001330.U00096.2161463_2162879.299	1	0	539	1184	mdtD	1416	1416	98.38	mdtD.l15.c4.ctg.1	1847	34.5	0	.	p	.	0	T226A	NONSYN	676	678	ACG	838	840	GCG	44;46;49	G;C;G	43;46;49	.	mdtD;Efflux pump mdtD
mdtD.3001330.U00096.2161463_2162879.299	mdtD.3001330.U00096.2161463_2162879.299	1	0	539	1184	mdtD	1416	1416	98.38	mdtD.l15.c4.ctg.1	1847	34.5	0	.	p	.	0	V340I	NONSYN	1018	1020	GTC	1180	1182	ATC	32;32;31	A;T;C	32;32;31	.	mdtD;Efflux pump mdtD
mdtD.3001330.U00096.2161463_2162879.299	mdtD.3001330.U00096.2161463_2162879.299	1	0	539	1184	mdtD	1416	1416	98.38	mdtD.l15.c4.ctg.1	1847	34.5	0	.	p	.	0	L441F	NONSYN	1321	1323	TTG	1483	1485	TTT	54;55;56	T;T;T,G	54;55;55,1	.	mdtD;Efflux pump mdtD
mdtE.3000795.AP009048.3980025_3981183.753	mdtE.3000795.AP009048.3980025_3981183.753	1	0	27	438	mdtE	1158	1158	99.31	mdtE.l15.c30.ctg.1	1541	15.1	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	MdtE is the membrane fusion protein of the MdtEF multidrug efflux complex. It shares 70% sequence similarity with AcrA.;mdtE
mdtF.3000796.U00096.3660413_3663527.286	mdtF.3000796.U00096.3660413_3663527.286	1	0	539	986	mdtF	3114	3114	98.52	mdtF.l6.c4.ctg.1	3492	15.1	0	.	p	.	0	A295T	NONSYN	883	885	GCC	1084	1086	ACC	11;11;11	A;C;C	11;9;11	.	MdtF is the multidrug inner membrane transporter for the MdtEF-TolC efflux complex.;mdtF
mdtF.3000796.U00096.3660413_3663527.286	mdtF.3000796.U00096.3660413_3663527.286	1	0	539	986	mdtF	3114	3114	98.52	mdtF.l6.c4.ctg.1	3492	15.1	0	.	p	.	0	N709D	NONSYN	2125	2127	AAT	2326	2328	GAC	15;15;15	G;A;C	15;15;15	.	MdtF is the multidrug inner membrane transporter for the MdtEF-TolC efflux complex.;mdtF
mdtG.3001329.NC_007779.1115840_1117067.599	mdtG.3001329.NC_007779.1115840_1117067.599	1	0	513	306	mdtG	1227	1047	99.43	mdtG.l15.c4.ctg.1	1307	10.2	0	.	p	.	0	V200I	NONSYN	598	600	GTC	610	612	ATC	7;6;6	A;T;C	7;6;6	.	mdtG;Efflux protien mdtG.
mdtG.3001329.NC_007779.1115840_1117067.599	mdtG.3001329.NC_007779.1115840_1117067.599	1	0	513	306	mdtG	1227	176	99.43	mdtG.l15.c4.ctg.2	183	6.2	0	.	p	.	0	E5G	NONSYN	13	15	GAA	7	9	GGA	3;3;3	G;G;A	3;3;3	.	mdtG;Efflux protien mdtG.
mdtH.3001216.U00096.1124117_1125326.120	mdtH.3001216.U00096.1124117_1125326.120	1	0	539	258	mdtH	1209	1209	98.1	mdtH.l6.c4.ctg.1	1281	10.2	0	.	p	.	0	G134C	NONSYN	400	402	GGT	414	416	TGT	9;9;9	T;G;T	9;9;9	.	mdtH;Multidrug resistance protein MdtH
mdtH.3001216.U00096.1124117_1125326.120	mdtH.3001216.U00096.1124117_1125326.120	1	0	539	258	mdtH	1209	1209	98.1	mdtH.l6.c4.ctg.1	1281	10.2	0	.	p	.	0	S324L	NONSYN	970	972	TCG	984	986	TTG	13;13;13	T;T;G	13;13;13	.	mdtH;Multidrug resistance protein MdtH
mdtH.3001216.U00096.1124117_1125326.120	mdtH.3001216.U00096.1124117_1125326.120	1	0	539	258	mdtH	1209	1209	98.1	mdtH.l6.c4.ctg.1	1281	10.2	0	.	p	.	0	L359Q	NONSYN	1075	1077	CTG	1089	1091	CAG	4;4;4	C;A;G	4;4;4	.	mdtH;Multidrug resistance protein MdtH
mdtH.3001216.U00096.1124117_1125326.120	mdtH.3001216.U00096.1124117_1125326.120	1	0	539	258	mdtH	1209	1209	98.1	mdtH.l6.c4.ctg.1	1281	10.2	0	.	p	.	0	A394T	NONSYN	1180	1182	GCG	1194	1196	ACG	6;6;8	A;C;G	6;6;8	.	mdtH;Multidrug resistance protein MdtH
mdtL.3001215.U00096.3891614_3892790.621	mdtL.3001215.U00096.3891614_3892790.621	1	0	539	390	mdtL	1176	1176	98.47	mdtL.l15.c4.ctg.1	1583	13.2	0	.	p	.	0	A185S	NONSYN	553	555	GCC	759	761	TCC	13;13;11	T;C;C	12;13;11	.	mdtL;Multidrug resistance protein MdtL
mdtN.3003548.AP009048.4306556_4307588.3298	mdtN.3003548.AP009048.4306556_4307588.3298	1	0	539	264	mdtN	1032	1032	98.16	mdtN.l6.c4.ctg.1	1375	10.2	0	.	p	.	0	V119I	NONSYN	355	357	GTT	521	523	ATT	5;5;5	A;T;T	5;5;5	.	Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride.;mdtN
mdtO.3003549.AP009048.4304505_4306557.3300	mdtO.3003549.AP009048.4304505_4306557.3300	1	0	531	510	mdtO	2052	2037	98.09	mdtO.l6.c4.ctg.1	2239	12.0	0	.	p	.	0	V11M	NONSYN	31	33	GTG	16	18	ATG	9;9;9	A;T;G	7;7;7	.	mdtO;Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride
mdtO.3003549.AP009048.4304505_4306557.3300	mdtO.3003549.AP009048.4304505_4306557.3300	1	0	531	510	mdtO	2052	2037	98.09	mdtO.l6.c4.ctg.1	2239	12.0	0	.	p	.	0	T33I	NONSYN	97	99	ACC	82	84	ATC	7;7;7	A;T;C	7;6;7	.	mdtO;Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride
mdtO.3003549.AP009048.4304505_4306557.3300	mdtO.3003549.AP009048.4304505_4306557.3300	1	0	531	510	mdtO	2052	2037	98.09	mdtO.l6.c4.ctg.1	2239	12.0	0	.	p	.	0	C116R	NONSYN	346	348	TGC	331	333	CGC	14;15;15	C;G;C	14;15;15	.	mdtO;Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride
mdtO.3003549.AP009048.4304505_4306557.3300	mdtO.3003549.AP009048.4304505_4306557.3300	1	0	531	510	mdtO	2052	2037	98.09	mdtO.l6.c4.ctg.1	2239	12.0	0	.	p	.	0	N238S	NONSYN	712	714	AAC	697	699	AGC	17;16;16	A;G;C	17;16;16	.	mdtO;Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride
mdtO.3003549.AP009048.4304505_4306557.3300	mdtO.3003549.AP009048.4304505_4306557.3300	1	0	531	510	mdtO	2052	2037	98.09	mdtO.l6.c4.ctg.1	2239	12.0	0	.	p	.	0	M305V	NONSYN	913	915	ATG	898	900	GTG	14;14;14	G;T;G	14;13;14	.	mdtO;Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride
mdtO.3003549.AP009048.4304505_4306557.3300	mdtO.3003549.AP009048.4304505_4306557.3300	1	0	531	510	mdtO	2052	2037	98.09	mdtO.l6.c4.ctg.1	2239	12.0	0	.	p	.	0	D326N	NONSYN	976	978	GAC	961	963	AAC	5;5;5	A;A;C	5;5;5	.	mdtO;Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride
mdtO.3003549.AP009048.4304505_4306557.3300	mdtO.3003549.AP009048.4304505_4306557.3300	1	0	531	510	mdtO	2052	2037	98.09	mdtO.l6.c4.ctg.1	2239	12.0	0	.	p	.	0	A341V	NONSYN	1021	1023	GCC	1006	1008	GTC	8;8;9	G;T;C	8;8;9	.	mdtO;Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride
mdtO.3003549.AP009048.4304505_4306557.3300	mdtO.3003549.AP009048.4304505_4306557.3300	1	0	531	510	mdtO	2052	2037	98.09	mdtO.l6.c4.ctg.1	2239	12.0	0	.	p	.	0	M351I	NONSYN	1051	1053	ATG	1036	1038	ATA	19;19;19	A;T;A	19;19;19	.	mdtO;Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride
mdtO.3003549.AP009048.4304505_4306557.3300	mdtO.3003549.AP009048.4304505_4306557.3300	1	0	531	510	mdtO	2052	2037	98.09	mdtO.l6.c4.ctg.1	2239	12.0	0	.	p	.	0	A387S	NONSYN	1159	1161	GCT	1144	1146	TCT	10;10;9	T;C;T	10;10;9	.	mdtO;Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride
mdtO.3003549.AP009048.4304505_4306557.3300	mdtO.3003549.AP009048.4304505_4306557.3300	1	0	531	510	mdtO	2052	2037	98.09	mdtO.l6.c4.ctg.1	2239	12.0	0	.	p	.	0	T516A	NONSYN	1546	1548	ACG	1531	1533	GCG	10;10;10	G;C;G	10;10;10	.	mdtO;Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride
mdtO.3003549.AP009048.4304505_4306557.3300	mdtO.3003549.AP009048.4304505_4306557.3300	1	0	531	510	mdtO	2052	2037	98.09	mdtO.l6.c4.ctg.1	2239	12.0	0	.	p	.	0	G584S	NONSYN	1750	1752	GGC	1735	1737	AGC	11;11;11	A;G;C	11;11;11	.	mdtO;Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride
mdtO.3003549.AP009048.4304505_4306557.3300	mdtO.3003549.AP009048.4304505_4306557.3300	1	0	531	510	mdtO	2052	2037	98.09	mdtO.l6.c4.ctg.1	2239	12.0	0	.	p	.	0	L587I	NONSYN	1759	1761	CTT	1744	1746	ATC	14;14;14	A;T;C	14;14;14	.	mdtO;Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride
mdtP.3003550.AP009048.4303042_4304509.3303	mdtP.3003550.AP009048.4303042_4304509.3303	1	0	531	356	mdtP	1467	1454	97.94	mdtP.l15.c4.ctg.1	1553	11.7	0	.	p	.	0	S129A	NONSYN	385	387	TCA	484	486	GCG	12;13;13	G;C;G	12;12;12	.	Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride;mdtP
mdtP.3003550.AP009048.4303042_4304509.3303	mdtP.3003550.AP009048.4303042_4304509.3303	1	0	531	356	mdtP	1467	1454	97.94	mdtP.l15.c4.ctg.1	1553	11.7	0	.	p	.	0	A187T	NONSYN	559	561	GCC	658	660	ACC	13;15;15	A;C;C	13;15;14	.	Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride;mdtP
mdtP.3003550.AP009048.4303042_4304509.3303	mdtP.3003550.AP009048.4303042_4304509.3303	1	0	531	356	mdtP	1467	1454	97.94	mdtP.l15.c4.ctg.1	1553	11.7	0	.	p	.	0	H211R	NONSYN	631	633	CAC	730	732	CGC	9;8;8	C;G;C	9;8;8	.	Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride;mdtP
mdtP.3003550.AP009048.4303042_4304509.3303	mdtP.3003550.AP009048.4303042_4304509.3303	1	0	531	356	mdtP	1467	1454	97.94	mdtP.l15.c4.ctg.1	1553	11.7	0	.	p	.	0	V250A	NONSYN	748	750	GTT	847	849	GCT	16;16;16	G;C;T	16;16;16	.	Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride;mdtP
mdtP.3003550.AP009048.4303042_4304509.3303	mdtP.3003550.AP009048.4303042_4304509.3303	1	0	531	356	mdtP	1467	1454	97.94	mdtP.l15.c4.ctg.1	1553	11.7	0	.	p	.	0	R278K	NONSYN	832	834	AGA	931	933	AAA	4;4;5	A;A;A	4;4;5	.	Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride;mdtP
mdtP.3003550.AP009048.4303042_4304509.3303	mdtP.3003550.AP009048.4303042_4304509.3303	1	0	531	356	mdtP	1467	1454	97.94	mdtP.l15.c4.ctg.1	1553	11.7	0	.	p	.	0	Q284R	NONSYN	850	852	CAA	949	951	CGA	5;5;5	C;G;A	5;5;5	.	Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride;mdtP
mdtP.3003550.AP009048.4303042_4304509.3303	mdtP.3003550.AP009048.4303042_4304509.3303	1	0	531	356	mdtP	1467	1454	97.94	mdtP.l15.c4.ctg.1	1553	11.7	0	.	p	.	0	S339A	NONSYN	1015	1017	TCC	1114	1116	GCC	3;4;4	G;C;C	3;4;4	.	Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride;mdtP
mdtP.3003550.AP009048.4303042_4304509.3303	mdtP.3003550.AP009048.4303042_4304509.3303	1	0	531	356	mdtP	1467	1454	97.94	mdtP.l15.c4.ctg.1	1553	11.7	0	.	p	.	0	H343D	NONSYN	1027	1029	CAT	1126	1128	GAT	3;3;3	G;A;T	3;3;3	.	Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride;mdtP
mdtP.3003550.AP009048.4303042_4304509.3303	mdtP.3003550.AP009048.4303042_4304509.3303	1	0	531	356	mdtP	1467	1454	97.94	mdtP.l15.c4.ctg.1	1553	11.7	0	.	p	.	0	G482A	NONSYN	1444	1446	GGT	1543	1545	GCT	8;7;6	G;C;T	8;7;6	.	Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride;mdtP
mfd.3003844.NC_000913.3.1170517_1173964.3609	mfd.3003844.NC_000913.3.1170517_1173964.3609	1	0	531	872	mfd	3447	3437	99.16	mfd.l15.c30.ctg.1	3573	12.5	0	.	p	.	0	T437K	NONSYN	1309	1311	ACG	1299	1301	AAG	6;6;6	A;A;G	6;6;5	.	mfd;mfd dissociates transcription elongation complexes blocked at nonpairing lesions and mediates recruitment of DNA repair proteins. The Mfd (mutation frequency decline) protein, also known as transcription-repair coupling factor, is responsible for ATP-dependent removal of stalled RNA polymerase from DNA lesions by inducing forward movement of the RNA polymerase and subsequent recruitment of nucleotide excision repair machinery to the sites of the lesions.
mfd.3003844.NC_000913.3.1170517_1173964.3609	mfd.3003844.NC_000913.3.1170517_1173964.3609	1	0	531	872	mfd	3447	3437	99.16	mfd.l15.c30.ctg.1	3573	12.5	0	.	p	.	0	M796L	NONSYN	2386	2388	ATG	2376	2378	CTG	11;12;12	C;T;G	11;12;12	.	mfd;mfd dissociates transcription elongation complexes blocked at nonpairing lesions and mediates recruitment of DNA repair proteins. The Mfd (mutation frequency decline) protein, also known as transcription-repair coupling factor, is responsible for ATP-dependent removal of stalled RNA polymerase from DNA lesions by inducing forward movement of the RNA polymerase and subsequent recruitment of nucleotide excision repair machinery to the sites of the lesions.
mgrB.3003820.NC_000913.3.1908622_1908766.3586	mgrB.3003820.NC_000913.3.1908622_1908766.3586	1	0	19	80	mgrB	144	142	100.0	mgrB.l15.c4.ctg.2	159	13.6	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	mgrB;mgrB is a small transmembrane protein produced in the PhoPQ signalling system. It acts as a negative regulator in this system. Inactivation or down-regulation of mgrB confers colistin resistance by absence as shown in Klebsiella pneumoniae
msbA.3003950.NC_000913.3.966620_968369.3754	msbA.3003950.NC_000913.3.966620_968369.3754	1	0	539	480	msbA	1749	1749	98.68	msbA.l15.c4.ctg.1	2015	12.6	0	.	p	.	0	S278N	NONSYN	832	834	AGC	1016	1018	AAC	16;16;16	A;A;C	16;15;16	.	msbA;MsbA is a multidrug resistance transporter homolog from E. coli and belongs to a superfamily of transporters that contain an adenosine triphosphate (ATP) binding cassette (ABC) which is also called a nucleotide-binding domain (NBD). MsbA is a member of the MDR-ABC transporter group by sequence homology. MsbA transports lipid A, a major component of the bacterial outer cell membrane, and is the only bacterial ABC transporter that is essential for cell viability.
msbA.3003950.NC_000913.3.966620_968369.3754	msbA.3003950.NC_000913.3.966620_968369.3754	1	0	539	480	msbA	1749	1749	98.68	msbA.l15.c4.ctg.1	2015	12.6	0	.	p	.	0	M460I	NONSYN	1378	1380	ATG	1562	1564	ATA	9;9;7	A;T;A	8;9;7	.	msbA;MsbA is a multidrug resistance transporter homolog from E. coli and belongs to a superfamily of transporters that contain an adenosine triphosphate (ATP) binding cassette (ABC) which is also called a nucleotide-binding domain (NBD). MsbA is a member of the MDR-ABC transporter group by sequence homology. MsbA transports lipid A, a major component of the bacterial outer cell membrane, and is the only bacterial ABC transporter that is essential for cell viability.
murA.3003775.CP009072.1414817_1416077.3548	murA.3003775.CP009072.1414817_1416077.3548	1	1	539	330	murA_12	1260	1260	98.49	murA_12.l15.c30.ctg.1	1626	10.8	0	.	p	.	0	A343V	NONSYN	1027	1029	GCG	1212	1214	GTG	10;8;8	G;T;G	10;8;8	.	Escherichia coli mutant murA conferring resistance to fosfomycin
murA.3003775.CP009072.1414817_1416077.3548	murA.3003775.CP009072.1414817_1416077.3548	1	1	539	330	murA_12	1260	1260	98.49	murA_12.l15.c30.ctg.1	1626	10.8	1	SNP	p	D369N	0	.	.	1105	1107	GAT	1290	1292	GAT	11;11;11	G;A;T	11;11;11	murA.3003775.CP009072.1414817_1416077.3548:1:1:D369N:.:murA or UDP-N-acetylglucosamine enolpyruvyl transferase catalyses the initial step in peptidoglycan biosynthesis and is inhibited by fosfomycin. Overexpression of murA through mutations such as Asp369Asn and Leu370Ile confers fosfomycin resistance. Extensive evidence has shown the significance of C115 mutations in conferring fosfomycin resistance since this residue represents a primary binding site for the antibiotic across many species.	Escherichia coli mutant murA conferring resistance to fosfomycin
murA.3003775.CP009072.1414817_1416077.3548	murA.3003775.CP009072.1414817_1416077.3548	1	1	539	330	murA_12	1260	1260	98.49	murA_12.l15.c30.ctg.1	1626	10.8	1	SNP	p	L370I	0	.	.	1108	1110	CTG	1293	1295	CTG	11;11;11	C;T;G	11;11;11	murA.3003775.CP009072.1414817_1416077.3548:1:1:L370I:.:murA or UDP-N-acetylglucosamine enolpyruvyl transferase catalyses the initial step in peptidoglycan biosynthesis and is inhibited by fosfomycin. Overexpression of murA through mutations such as Asp369Asn and Leu370Ile confers fosfomycin resistance. Extensive evidence has shown the significance of C115 mutations in conferring fosfomycin resistance since this residue represents a primary binding site for the antibiotic across many species.	Escherichia coli mutant murA conferring resistance to fosfomycin
nfsA.3003751.NC_000913.3.891183_891906.3520	nfsA.3003751.NC_000913.3.891183_891906.3520	1	1	539	230	nfsA	723	723	99.03	nfsA.l6.c30.ctg.1	1056	11.4	0	.	p	.	0	R27C	NONSYN	79	81	CGT	235	237	TGT	8;8;8	T;G;T	8;8;8	.	Escherichia coli nfsA mutations conferring resistance to nitrofurantoin
nfsA.3003751.NC_000913.3.891183_891906.3520	nfsA.3003751.NC_000913.3.891183_891906.3520	1	1	539	230	nfsA	723	723	99.03	nfsA.l6.c30.ctg.1	1056	11.4	0	.	p	.	0	I117T	NONSYN	349	351	ATC	505	507	ACC	15;16;16	A;C;C	14;16;16	.	Escherichia coli nfsA mutations conferring resistance to nitrofurantoin
nfsA.3003751.NC_000913.3.891183_891906.3520	nfsA.3003751.NC_000913.3.891183_891906.3520	1	1	539	230	nfsA	723	723	99.03	nfsA.l6.c30.ctg.1	1056	11.4	0	.	p	.	0	G187D	NONSYN	559	561	GGC	715	717	GAC	13;13;14	G;A;C	13;13;14	.	Escherichia coli nfsA mutations conferring resistance to nitrofurantoin
nfsA.3003751.NC_000913.3.891183_891906.3520	nfsA.3003751.NC_000913.3.891183_891906.3520	1	1	539	230	nfsA	723	723	99.03	nfsA.l6.c30.ctg.1	1056	11.4	1	SNP	p	R15C	0	.	.	43	45	CGC	199	201	CGC	11;11;12	C;G;C	11;11;12	nfsA.3003751.NC_000913.3.891183_891906.3520:1:1:R15C:.:nfsA encodes the major oxygen-insesitive nitroreductase in E. coli. The first step of resistance to nitrofurazone is mutation of nfsA.	Escherichia coli nfsA mutations conferring resistance to nitrofurantoin
nfsA.3003751.NC_000913.3.891183_891906.3520	nfsA.3003751.NC_000913.3.891183_891906.3520	1	1	539	230	nfsA	723	723	99.03	nfsA.l6.c30.ctg.1	1056	11.4	1	SNP	p	S33R	0	.	.	97	99	AGC	253	255	AGC	5;5;4	A;G;C	5;5;4	nfsA.3003751.NC_000913.3.891183_891906.3520:1:1:S33R:.:nfsA encodes the major oxygen-insesitive nitroreductase in E. coli. The first step of resistance to nitrofurazone is mutation of nfsA.	Escherichia coli nfsA mutations conferring resistance to nitrofurantoin
nfsA.3003751.NC_000913.3.891183_891906.3520	nfsA.3003751.NC_000913.3.891183_891906.3520	1	1	539	230	nfsA	723	723	99.03	nfsA.l6.c30.ctg.1	1056	11.4	1	SNP	p	G131D	0	.	.	391	393	GGC	547	549	GGC	17;17;16	G;G;C	17;17;14	nfsA.3003751.NC_000913.3.891183_891906.3520:1:1:G131D:.:nfsA encodes the major oxygen-insesitive nitroreductase in E. coli. The first step of resistance to nitrofurazone is mutation of nfsA.	Escherichia coli nfsA mutations conferring resistance to nitrofurantoin
nfsA.3003751.NC_000913.3.891183_891906.3520	nfsA.3003751.NC_000913.3.891183_891906.3520	1	1	539	230	nfsA	723	723	99.03	nfsA.l6.c30.ctg.1	1056	11.4	1	SNP	p	R203C	0	.	.	607	609	CGT	763	765	CGT	15;16;16	C;G;T,A	15;16;15,1	nfsA.3003751.NC_000913.3.891183_891906.3520:1:1:R203C:.:nfsA encodes the major oxygen-insesitive nitroreductase in E. coli. The first step of resistance to nitrofurazone is mutation of nfsA.	Escherichia coli nfsA mutations conferring resistance to nitrofurantoin
nfsA.3003751.NC_000913.3.891183_891906.3520	nfsA.3003751.NC_000913.3.891183_891906.3520	1	1	539	230	nfsA	723	723	99.03	nfsA.l6.c30.ctg.1	1056	11.4	1	SNP	p	R203L	0	.	.	607	609	CGT	763	765	CGT	15;16;16	C;G;T,A	15;16;15,1	nfsA.3003751.NC_000913.3.891183_891906.3520:1:1:R203L:.:nfsA encodes the major oxygen-insesitive nitroreductase in E. coli. The first step of resistance to nitrofurazone is mutation of nfsA.	Escherichia coli nfsA mutations conferring resistance to nitrofurantoin
ompF.3003390.NC_007779.986315_987404.2075	ompF.3003390.NC_007779.986315_987404.2075	1	1	27	404	ompF	1089	1089	100.0	ompF.l15.c30.ctg.1	1328	15.7	1	SNP	p	G141D	0	.	.	421	423	GGT	460	462	GGT	14;14;13	G;G;T	14;14;13	ompF.3003390.NC_007779.986315_987404.2075:1:1:G141D:.:Mutant forms of the Escherichia coli outer membrane porin OmpF result in reduced permeability to antibiotics.	Escherichia coli ompF mutants
ompF.3003390.NC_007779.986315_987404.2075	ompF.3003390.NC_007779.986315_987404.2075	1	1	27	404	ompF	1089	1089	100.0	ompF.l15.c30.ctg.1	1328	15.7	1	SNP	p	G141E	0	.	.	421	423	GGT	460	462	GGT	14;14;13	G;G;T	14;14;13	ompF.3003390.NC_007779.986315_987404.2075:1:1:G141E:.:Mutant forms of the Escherichia coli outer membrane porin OmpF result in reduced permeability to antibiotics.	Escherichia coli ompF mutants
ompF.3003390.NC_007779.986315_987404.2075	ompF.3003390.NC_007779.986315_987404.2075	1	1	27	404	ompF	1089	1089	100.0	ompF.l15.c30.ctg.1	1328	15.7	1	SNP	p	R154D	0	.	.	460	462	CGT	499	501	CGT	23;23;22	C;G;T	23;23;22	ompF.3003390.NC_007779.986315_987404.2075:1:1:R154D:.:Mutant forms of the Escherichia coli outer membrane porin OmpF result in reduced permeability to antibiotics.	Escherichia coli ompF mutants
ompF.3003390.NC_007779.986315_987404.2075	ompF.3003390.NC_007779.986315_987404.2075	1	1	27	404	ompF	1089	1089	100.0	ompF.l15.c30.ctg.1	1328	15.7	1	SNP	p	R154A	0	.	.	460	462	CGT	499	501	CGT	23;23;22	C;G;T	23;23;22	ompF.3003390.NC_007779.986315_987404.2075:1:1:R154A:.:Mutant forms of the Escherichia coli outer membrane porin OmpF result in reduced permeability to antibiotics.	Escherichia coli ompF mutants
parC.3003941.NC_004337.2.3159154_3161413.3742	parC.3003941.NC_004337.2.3159154_3161413.3742	1	1	539	760	parC_2	2259	2259	99.29	parC_2.l15.c4.ctg.1	2641	15.5	0	.	p	.	0	P542S	NONSYN	1624	1626	CCG	1840	1842	TCG	14;14;14	T;C;G	14;14;14	.	Shigella flexneri parC conferring resistance to fluoroquinolones
parC.3003941.NC_004337.2.3159154_3161413.3742	parC.3003941.NC_004337.2.3159154_3161413.3742	1	1	539	760	parC_2	2259	2259	99.29	parC_2.l15.c4.ctg.1	2641	15.5	0	.	p	.	0	S747N	NONSYN	2239	2241	AGC	2455	2457	AAC	11;10;10	A;A;C	11;10;10	.	Shigella flexneri parC conferring resistance to fluoroquinolones
parC.3003941.NC_004337.2.3159154_3161413.3742	parC.3003941.NC_004337.2.3159154_3161413.3742	1	1	539	760	parC_2	2259	2259	99.29	parC_2.l15.c4.ctg.1	2641	15.5	1	SNP	p	A85T	0	.	.	253	255	GCG	469	471	GCG	12;12;12	G;C;G	12;12;12	parC.3003941.NC_004337.2.3159154_3161413.3742:1:1:A85T:.:Point mutation in parC conferring resistance to fluoroquinolone antibiotics in Shigella flexneri,	Shigella flexneri parC conferring resistance to fluoroquinolones
parC.3003941.NC_004337.2.3159154_3161413.3742	parC.3003941.NC_004337.2.3159154_3161413.3742	1	1	539	760	parC_2	2259	2259	99.29	parC_2.l15.c4.ctg.1	2641	15.5	1	SNP	p	D111H	0	.	.	331	333	GAT	547	549	GAT	12;10;10	G;A;T	12;10;10	parC.3003941.NC_004337.2.3159154_3161413.3742:1:1:D111H:.:Point mutation in parC conferring resistance to fluoroquinolone antibiotics in Shigella flexneri,	Shigella flexneri parC conferring resistance to fluoroquinolones
parC.3003941.NC_004337.2.3159154_3161413.3742	parC.3003941.NC_004337.2.3159154_3161413.3742	1	1	539	760	parC_2	2259	2259	99.29	parC_2.l15.c4.ctg.1	2641	15.5	1	SNP	p	S129P	0	.	.	385	387	TCC	601	603	TCC	15;15;15	T;C;C	14;15;15	parC.3003941.NC_004337.2.3159154_3161413.3742:1:1:S129P:.:Point mutation in parC conferring resistance to fluoroquinolone antibiotics in Shigella flexneri,	Shigella flexneri parC conferring resistance to fluoroquinolones
parE.3003316.NC_007779.3172159_3174052.2073	parE.3003316.NC_007779.3172159_3174052.2073	1	1	3	462	parE_1	1893	1750	97.49	parE_1.l15.c4.ctg.1	1948	11.3	1	SNP	p	D476N	0	.	.	1426	1428	GAT	1283	1285	GAT	15;15;15	G;A;T	15;15;15	parE.3003316.NC_007779.3172159_3174052.2073:1:1:D476N:.:Point mutation in Escherichia coli parE resulting in fluoroquinolones resistance	Escherichia coli parE conferring resistance to fluoroquinolones
parE.3003316.NC_007779.3172159_3174052.2073	parE.3003316.NC_007779.3172159_3174052.2073	1	1	3	462	parE_1	1893	109	100.0	parE_1.l15.c4.ctg.3	141	11.5	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Escherichia coli parE conferring resistance to fluoroquinolones
patA.3000024.NC_000913.3.3219493_3220873.3692	patA.3000024.NC_000913.3.3219493_3220873.3692	1	0	539	424	patA	1380	1380	99.86	patA.l15.c4.ctg.1	1760	12.9	0	.	p	.	0	E360D	NONSYN	1078	1080	GAG	1247	1249	GAT	12;12;12	G;A;T	12;12;12	.	patA;PatA is an ABC transporter of Streptococcus pneumoniae that interacts with PatB to confer fluoroquinolone resistance.
rpoB.3003288.NC_002695.4990140_4994169.2096	rpoB.3003288.NC_002695.4990140_4994169.2096	1	1	27	1292	rpoB	4029	4029	99.01	rpoB.l15.c30.ctg.1	4396	15.8	1	SNP	p	V146F	0	.	.	436	438	GTT	627	629	GTT	18;17;17	G;T;T	18;17;17	rpoB.3003288.NC_002695.4990140_4994169.2096:1:1:V146F:.:Point mutations that occurs in Escherichia coli rpoB resulting in resistance to rifampicin	Escherichia coli rpoB mutants conferring resistance to rifampicin
rpoB.3003288.NC_002695.4990140_4994169.2096	rpoB.3003288.NC_002695.4990140_4994169.2096	1	1	27	1292	rpoB	4029	4029	99.01	rpoB.l15.c30.ctg.1	4396	15.8	1	SNP	p	Q513P	0	.	.	1537	1539	CAG	1728	1730	CAG	12;11;13	C;A;G	12;11;13	rpoB.3003288.NC_002695.4990140_4994169.2096:1:1:Q513P:.:Point mutations that occurs in Escherichia coli rpoB resulting in resistance to rifampicin	Escherichia coli rpoB mutants conferring resistance to rifampicin
rpoB.3003288.NC_002695.4990140_4994169.2096	rpoB.3003288.NC_002695.4990140_4994169.2096	1	1	27	1292	rpoB	4029	4029	99.01	rpoB.l15.c30.ctg.1	4396	15.8	1	SNP	p	Q513L	0	.	.	1537	1539	CAG	1728	1730	CAG	12;11;13	C;A;G	12;11;13	rpoB.3003288.NC_002695.4990140_4994169.2096:1:1:Q513L:.:Point mutations that occurs in Escherichia coli rpoB resulting in resistance to rifampicin	Escherichia coli rpoB mutants conferring resistance to rifampicin
rpoB.3003288.NC_002695.4990140_4994169.2096	rpoB.3003288.NC_002695.4990140_4994169.2096	1	1	27	1292	rpoB	4029	4029	99.01	rpoB.l15.c30.ctg.1	4396	15.8	1	SNP	p	H526Y	0	.	.	1576	1578	CAC	1767	1769	CAC	20;20;20	C;A;C	20;20;20	rpoB.3003288.NC_002695.4990140_4994169.2096:1:1:H526Y:.:Point mutations that occurs in Escherichia coli rpoB resulting in resistance to rifampicin	Escherichia coli rpoB mutants conferring resistance to rifampicin
rpoB.3003288.NC_002695.4990140_4994169.2096	rpoB.3003288.NC_002695.4990140_4994169.2096	1	1	27	1292	rpoB	4029	4029	99.01	rpoB.l15.c30.ctg.1	4396	15.8	1	SNP	p	R529S	0	.	.	1585	1587	CGT	1776	1778	CGT	20;20;20	C;G;T	20;20;19	rpoB.3003288.NC_002695.4990140_4994169.2096:1:1:R529S:.:Point mutations that occurs in Escherichia coli rpoB resulting in resistance to rifampicin	Escherichia coli rpoB mutants conferring resistance to rifampicin
rpoB.3003288.NC_002695.4990140_4994169.2096	rpoB.3003288.NC_002695.4990140_4994169.2096	1	1	27	1292	rpoB	4029	4029	99.01	rpoB.l15.c30.ctg.1	4396	15.8	1	SNP	p	R529C	0	.	.	1585	1587	CGT	1776	1778	CGT	20;20;20	C;G;T	20;20;19	rpoB.3003288.NC_002695.4990140_4994169.2096:1:1:R529C:.:Point mutations that occurs in Escherichia coli rpoB resulting in resistance to rifampicin	Escherichia coli rpoB mutants conferring resistance to rifampicin
rpoB.3003288.NC_002695.4990140_4994169.2096	rpoB.3003288.NC_002695.4990140_4994169.2096	1	1	27	1292	rpoB	4029	4029	99.01	rpoB.l15.c30.ctg.1	4396	15.8	1	SNP	p	S531F	0	.	.	1591	1593	TCC	1782	1784	TCC	22;22;20	T;C;C	22;22;20	rpoB.3003288.NC_002695.4990140_4994169.2096:1:1:S531F:.:Point mutations that occurs in Escherichia coli rpoB resulting in resistance to rifampicin	Escherichia coli rpoB mutants conferring resistance to rifampicin
rpoB.3003288.NC_002695.4990140_4994169.2096	rpoB.3003288.NC_002695.4990140_4994169.2096	1	1	27	1292	rpoB	4029	4029	99.01	rpoB.l15.c30.ctg.1	4396	15.8	1	SNP	p	L533P	0	.	.	1597	1599	CTC	1788	1790	CTC	18;18;18	C;T;C	18;18;18	rpoB.3003288.NC_002695.4990140_4994169.2096:1:1:L533P:.:Point mutations that occurs in Escherichia coli rpoB resulting in resistance to rifampicin	Escherichia coli rpoB mutants conferring resistance to rifampicin
rpoB.3003288.NC_002695.4990140_4994169.2096	rpoB.3003288.NC_002695.4990140_4994169.2096	1	1	27	1292	rpoB	4029	4029	99.01	rpoB.l15.c30.ctg.1	4396	15.8	1	SNP	p	T563P	0	.	.	1687	1689	ACC	1878	1880	ACC	21;21;21	A;C;C	21;21;21	rpoB.3003288.NC_002695.4990140_4994169.2096:1:1:T563P:.:Point mutations that occurs in Escherichia coli rpoB resulting in resistance to rifampicin	Escherichia coli rpoB mutants conferring resistance to rifampicin
rpoB.3003288.NC_002695.4990140_4994169.2096	rpoB.3003288.NC_002695.4990140_4994169.2096	1	1	27	1292	rpoB	4029	4029	99.01	rpoB.l15.c30.ctg.1	4396	15.8	1	SNP	p	P564L	0	.	.	1690	1692	CCT	1881	1883	CCT	17;18;18	C;C;T	17;18;18	rpoB.3003288.NC_002695.4990140_4994169.2096:1:1:P564L:.:Point mutations that occurs in Escherichia coli rpoB resulting in resistance to rifampicin	Escherichia coli rpoB mutants conferring resistance to rifampicin
rpoB.3003288.NC_002695.4990140_4994169.2096	rpoB.3003288.NC_002695.4990140_4994169.2096	1	1	27	1292	rpoB	4029	4029	99.01	rpoB.l15.c30.ctg.1	4396	15.8	1	SNP	p	R687H	0	.	.	2059	2061	CGT	2250	2252	CGT	12;12;12	C;G;T	12;12;12	rpoB.3003288.NC_002695.4990140_4994169.2096:1:1:R687H:.:Point mutations that occurs in Escherichia coli rpoB resulting in resistance to rifampicin	Escherichia coli rpoB mutants conferring resistance to rifampicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	659	3482	rrsB+	1542	1542	99.94	rrsB+.l6.c17.ctg.1	1867	96.6	0	.	n	.	0	A226G	SNP	226	226	A	372	372	G	115	G	115	.	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	659	3482	rrsB+	1542	1542	99.94	rrsB+.l6.c17.ctg.1	1867	96.6	1	SNP	n	A794T	0	.	.	794	794	A	940	940	A	101	A	101	rrsC.3003333.U00096.3941808_3943349.3229:0:0:A794T:.:Point mutations in the 3' minor, 3' major, and central domains in the rrsC 16S rRNA gene of Escherichia coli can confer resistance to kasugamicin	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	659	3482	rrsB+	1542	1542	99.94	rrsB+.l6.c17.ctg.1	1867	96.6	1	SNP	n	A794G	0	.	.	794	794	A	940	940	A	101	A	101	rrsC.3003333.U00096.3941808_3943349.3229:0:0:A794G:.:Point mutations in the 3' minor, 3' major, and central domains in the rrsC 16S rRNA gene of Escherichia coli can confer resistance to kasugamicin	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	659	3482	rrsB+	1542	1542	99.94	rrsB+.l6.c17.ctg.1	1867	96.6	1	SNP	n	G926A	0	.	.	926	926	G	1072	1072	G	135	G	134	rrsC.3003333.U00096.3941808_3943349.3229:0:0:G926A:.:Point mutations in the 3' minor, 3' major, and central domains in the rrsC 16S rRNA gene of Escherichia coli can confer resistance to kasugamicin	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	659	3482	rrsB+	1542	1542	99.94	rrsB+.l6.c17.ctg.1	1867	96.6	1	SNP	n	G926T	0	.	.	926	926	G	1072	1072	G	135	G	134	rrsC.3003333.U00096.3941808_3943349.3229:0:0:G926T:.:Point mutations in the 3' minor, 3' major, and central domains in the rrsC 16S rRNA gene of Escherichia coli can confer resistance to kasugamicin	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	659	3482	rrsB+	1542	1542	99.94	rrsB+.l6.c17.ctg.1	1867	96.6	1	SNP	n	G926C	0	.	.	926	926	G	1072	1072	G	135	G	134	rrsC.3003333.U00096.3941808_3943349.3229:0:0:G926C:.:Point mutations in the 3' minor, 3' major, and central domains in the rrsC 16S rRNA gene of Escherichia coli can confer resistance to kasugamicin	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	659	3482	rrsB+	1542	1542	99.94	rrsB+.l6.c17.ctg.1	1867	96.6	1	SNP	n	A1519G	0	.	.	1519	1519	A	1665	1665	A	107	A,T	105,1	rrsC.3003333.U00096.3941808_3943349.3229:0:0:A1519G:.:Point mutations in the 3' minor, 3' major, and central domains in the rrsC 16S rRNA gene of Escherichia coli can confer resistance to kasugamicin	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	659	3482	rrsB+	1542	1542	99.94	rrsB+.l6.c17.ctg.1	1867	96.6	1	SNP	n	A1519C	0	.	.	1519	1519	A	1665	1665	A	107	A,T	105,1	rrsC.3003333.U00096.3941808_3943349.3229:0:0:A1519C:.:Point mutations in the 3' minor, 3' major, and central domains in the rrsC 16S rRNA gene of Escherichia coli can confer resistance to kasugamicin	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	659	3482	rrsB+	1542	1542	99.94	rrsB+.l6.c17.ctg.1	1867	96.6	1	SNP	n	A1519T	0	.	.	1519	1519	A	1665	1665	A	107	A,T	105,1	rrsC.3003333.U00096.3941808_3943349.3229:0:0:A1519T:.:Point mutations in the 3' minor, 3' major, and central domains in the rrsC 16S rRNA gene of Escherichia coli can confer resistance to kasugamicin	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	659	3482	rrsB+	1542	1542	99.94	rrsB+.l6.c17.ctg.1	1867	96.6	0	HET	.	.	.	A79G	.	79	79	A	225	225	A	97	A,G	76,19	.	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	659	3482	rrsB+	1542	1542	99.94	rrsB+.l6.c17.ctg.1	1867	96.6	0	HET	.	.	.	C719T,G	.	719	719	C	865	865	C	101	C,T,G	57,43,1	.	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	659	3482	rrsB+	1542	1542	99.94	rrsB+.l6.c17.ctg.1	1867	96.6	0	HET	.	.	.	T273A	.	273	273	T	419	419	T	89	T,A	66,22	.	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	659	3482	rrsB+	1542	1542	99.94	rrsB+.l6.c17.ctg.1	1867	96.6	0	HET	.	.	.	T1010C	.	1010	1010	T	1156	1156	T	100	T,C	73,24	.	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	659	3482	rrsB+	1542	1542	99.94	rrsB+.l6.c17.ctg.1	1867	96.6	0	HET	.	.	.	C1038T	.	1038	1038	C	1184	1184	C	108	C,T	78,30	.	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	659	3482	rrsB+	1542	1542	99.94	rrsB+.l6.c17.ctg.1	1867	96.6	0	HET	.	.	.	C183T	.	183	183	C	329	329	C	98	C,T	67,30	.	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	659	3482	rrsB+	1542	1542	99.94	rrsB+.l6.c17.ctg.1	1867	96.6	0	HET	.	.	.	T90C	.	90	90	T	236	236	T	96	T,C	73,20	.	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	659	3482	rrsB+	1542	1542	99.94	rrsB+.l6.c17.ctg.1	1867	96.6	0	HET	.	.	.	A250T	.	250	250	A	396	396	A	114	A,T	86,28	.	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	659	3482	rrsB+	1542	1542	99.94	rrsB+.l6.c17.ctg.1	1867	96.6	0	HET	.	.	.	G474A	.	474	474	G	620	620	G	97	G,A	74,22	.	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	659	3482	rrsB+	1542	1542	99.94	rrsB+.l6.c17.ctg.1	1867	96.6	0	HET	.	.	.	A253T	.	253	253	A	399	399	A	113	A,T	84,28	.	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	659	3482	rrsB+	1542	1542	99.94	rrsB+.l6.c17.ctg.1	1867	96.6	0	HET	.	.	.	C194T	.	194	194	C	340	340	C	93	C,T	71,21	.	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	659	3482	rrsB+	1542	1542	99.94	rrsB+.l6.c17.ctg.1	1867	96.6	0	HET	.	.	.	G1002A	.	1002	1002	G	1148	1148	G	89	G,A	60,28	.	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	659	3482	rrsB+	1542	1542	99.94	rrsB+.l6.c17.ctg.1	1867	96.6	0	HET	.	.	.	G1006C	.	1006	1006	G	1152	1152	G	94	G,C	69,24	.	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
soxR.3003381.U00096.4277468_4277933.2074	soxR.3003381.U00096.4277468_4277933.2074	1	1	27	160	soxR	465	465	100.0	soxR.l6.c30.ctg.1	880	9.8	1	SNP	p	R20H	0	.	.	58	60	CGC	278	280	CGC	19;20;20	C;G;C	19;20;20	soxR.3003381.U00096.4277468_4277933.2074:1:1:R20H:.:SoxR is a sensory protein that upregulates soxS expression in the presence of redox-cycling drugs. This stress response leads to the expression many multidrug efflux pumps.	Escherichia coli soxR mutants
soxR.3003381.U00096.4277468_4277933.2074	soxR.3003381.U00096.4277468_4277933.2074	1	1	27	160	soxR	465	465	100.0	soxR.l6.c30.ctg.1	880	9.8	1	SNP	p	G121D	0	.	.	361	363	GGT	581	583	GGT	10;11;11	G;G;T	10;11;11	soxR.3003381.U00096.4277468_4277933.2074:1:1:G121D:.:SoxR is a sensory protein that upregulates soxS expression in the presence of redox-cycling drugs. This stress response leads to the expression many multidrug efflux pumps.	Escherichia coli soxR mutants
soxS.3003511.NC_000913.4277059_4277383.3528	soxS.3003511.NC_000913.4277059_4277383.3528	1	1	27	168	soxS_1	324	324	99.69	soxS_1.l15.c4.ctg.1	742	12.1	1	SNP	p	A12S	0	.	.	34	36	GCA	249	251	GCA	22;22;24	G;C;A	22;21;24	soxS.3003511.NC_000913.4277059_4277383.3528:1:1:A12S:.:SoxS is a global regulator that up-regulates the expression of AcrAB efflux genes. It also reduces OmpF expression to decrease cell membrane permeability.	Escherichia coli soxS mutant
tolC.3000237.FJ768952.0_1488.563	tolC.3000237.FJ768952.0_1488.563	1	0	27	484	tolC	1488	1488	98.72	tolC.l15.c30.ctg.1	1873	13.7	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	tolC;TolC is a protein subunit of many multidrug efflux complexes in Gram negative bacteria. It is an outer membrane efflux protein and is constitutively open. Regulation of efflux activity is often at its periplasmic entrance by other components of the efflux complex.
